TSS:Hg 79876.1

Basic information about the TSS

---

TSS ID: hg_79876.1 Species: human Chr: chr7		Start: 99409016 End: 99409027 Strand: +
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: S77329 U11861 Distance: 18 GeneID: 8896 HGNC/MGI_ID: HGNC:29629 UniProt_ID:

Gene_name: BUD31 homolog Gene_symbol: BUD31 Gene_synonyms: Cwc14 EDG-2 EDG2 YCR063W fSAP17 Gene_source: HGNC:29629

TATA-Box annotation

---

Distance to TSS:	53
Nearest PromoterID:	NM_001370410
Entrez ID:	8896
Nearest Unigene:	Hs.380233
Nearest Refseq:	NM_003910
Nearest Ensembl:	ENSG00000106245
Gene Name:	BUD31 homolog
Gene Alias:	Cwc14|EDG-2|EDG2|G10|YCR063W|fSAP17
Gene Description:	BUD31 homolog
Gene Type:	protein-coding
CpG%:	0.045
GC%:	0.58209
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@BUD31 p2@BUD31 p3@BUD31 p4@BUD31
Sample		p1@BUD31	p2@BUD31	p3@BUD31	p4@BUD31
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	82.60	20.26	8.77	1.75
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	74.45	27.52	13.76	4.25
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	75.43	21.61	9.65	3.67
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	66.53	14.14	6.24	2.29
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	71.09	20.25	8.32	3.37
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	68.03	19.77	8.92	1.74
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	78.66	18.52	11.77	3.70
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	76.78	16.23	8.96	2.42
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	61.98	18.38	6.63	2.56
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	165.77	41.73	15.65	5.22
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	151.99	33.96	15.77	6.47
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	124.41	35.78	13.01	6.91
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	53.68	3.06	2.26	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	55.03	3.46	2.86	1.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	55.77	4.39	2.20	1.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	56.33	4.02	2.77	0.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	51.33	2.84	2.18	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	45.56	2.95	1.27	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	66.11	3.20	0.53	2.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	58.97	2.86	2.41	1.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	56.40	3.07	2.41	1.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	68.53	3.80	2.76	1.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	61.14	3.75	2.97	1.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	53.14	2.18	2.18	2.43
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	66.30	5.16	1.81	1.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	64.88	3.80	2.22	2.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	68.68	2.20	1.65	2.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	64.83	4.72	2.36	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	52.82	4.04	1.29	1.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	65.87	2.53	1.45	1.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	56.52	4.61	2.30	1.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	62.72	3.52	3.71	0.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	59.51	5.91	3.38	1.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	98.30	5.77	2.47	3.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	66.19	3.74	1.68	3.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	56.15	4.60	1.72	1.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	64.38	5.72	1.43	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	64.07	2.82	3.02	1.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	75.90	6.75	3.24	1.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	70.10	5.76	3.12	1.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	65.64	4.23	1.88	1.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	88.28	5.56	2.78	3.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	64.32	5.27	2.32	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	74.48	4.72	3.32	1.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	74.49	4.02	2.61	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	78.17	4.65	2.33	1.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	57.58	4.32	2.88	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	81.96	8.35	2.09	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	70.62	4.31	1.68	2.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	85.13	4.04	3.03	2.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	91.82	5.53	1.84	1.43
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	80.28	6.00	1.78	1.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	811.55	13.99	27.98	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	54.29	4.61	2.48	1.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	52.03	3.98	2.65	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	373.33	9.23	2.52	2.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	156.60	5.51	1.38	3.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	54.77	6.16	1.30	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	50.74	6.74	2.57	1.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	195.20	7.54	1.57	4.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	43.71	3.53	0.71	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	51.59	5.05	0.56	1.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	310.50	4.78	0.00	9.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	145.08	4.42	0.34	2.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	55.24	4.22	1.62	1.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	66.38	5.32	1.06	1.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	1034.49	32.33	0.00	16.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	845.03	39.49	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	57.53	4.39	0.98	1.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	85.79	5.45	0.99	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	70.37	2.35	2.81	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	114.92	5.30	0.66	2.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	51.35	4.02	1.55	1.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	51.37	5.81	1.83	0.31
Adipocyte - breast, donor1	11376-118A8	102.63	4.28	1.27	1.27
Adipocyte - breast, donor2	11327-117E4	50.05	4.81	2.25	0.16
Adipocyte - omental, donor1	11473-119C6	94.02	5.60	3.31	1.15
Adipocyte - omental, donor2	11474-119C7	52.32	9.72	2.24	0.75
Adipocyte - omental, donor3	11475-119C8	60.29	5.02	1.34	1.00
Adipocyte - perirenal, donor1	11476-119C9	82.30	6.38	0.64	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	54.98	1.10	2.20	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	78.58	8.58	2.71	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	58.39	3.65	1.56	1.22
Adipocyte differentiation, day04, donor1	13019-139D4	74.51	1.56	0.98	0.98
Adipocyte differentiation, day04, donor2	13022-139D7	51.73	1.54	1.03	1.54
Adipocyte differentiation, day04, donor3	13025-139E1	56.03	4.46	0.28	0.56
Adipocyte differentiation, day04, donor4	13028-139E4	65.25	2.35	0.59	1.76
Adipocyte differentiation, day08, donor1	13020-139D5	61.53	3.62	2.41	1.13
Adipocyte differentiation, day08, donor2	13023-139D8	65.52	2.26	0.65	0.97
Adipocyte differentiation, day08, donor3	13026-139E2	44.25	5.33	0.00	2.13
Adipocyte differentiation, day08, donor4	13029-139E5	44.51	1.11	1.11	1.11
Adipocyte differentiation, day12, donor1	13021-139D6	52.82	5.41	2.08	1.66
Adipocyte differentiation, day12, donor2	13024-139D9	48.73	0.75	1.26	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	50.72	4.58	2.62	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	36.54	4.57	2.74	0.91
Alveolar Epithelial Cells, donor1	11510-119G7	79.56	7.51	4.64	2.43
Alveolar Epithelial Cells, donor2	11590-120G6	24.02	3.23	3.23	0.72
Alveolar Epithelial Cells, donor3	11671-122G6	15.57	2.40	0.00	1.20
Amniotic Epithelial Cells, donor1	11533-120A3	50.37	7.92	5.58	4.14
Amniotic Epithelial Cells, donor2	11613-122A2	28.45	10.04	3.35	3.35
Amniotic Epithelial Cells, donor3	11694-123A2	38.83	5.55	3.29	1.03
Anulus Pulposus Cell, donor1	11248-116E6	90.51	4.12	2.63	3.20
Anulus Pulposus Cell, donor2	11463-119B5	50.94	1.96	2.20	3.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	69.64	7.19	0.45	2.70
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	71.63	5.21	4.34	2.60
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	49.23	4.28	2.14	2.14
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	61.88	8.07	2.39	1.79
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	86.00	6.32	0.00	2.53
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	54.13	2.64	2.64	3.30
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	64.98	4.55	1.95	0.97
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	62.62	6.80	2.43	1.94
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	62.95	2.38	4.75	2.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	77.96	5.65	4.14	2.64
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	58.78	0.73	6.53	1.45
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	38.87	2.51	0.00	1.25
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	79.24	5.77	2.14	2.14
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	55.96	5.46	1.36	2.73
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	71.93	4.22	2.26	2.11
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	60.54	4.82	2.68	3.75
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	64.05	4.16	1.70	2.46
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	62.81	3.74	4.28	1.60
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	50.72	4.88	1.95	2.93
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	64.19	3.98	3.81	1.33
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	55.23	6.00	1.20	2.40
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	60.18	3.54	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	54.55	3.60	5.32	1.03
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	29.36	4.19	4.19	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	69.42	4.85	2.43	3.88
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	75.51	4.55	2.66	3.04
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	37.55	6.06	3.63	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	62.13	3.99	3.42	2.28
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	60.28	4.49	4.06	2.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	54.72	4.90	1.81	2.58
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	74.60	3.28	2.35	1.41
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	59.81	3.22	5.14	1.93
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	68.49	6.42	2.85	1.43
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	62.59	7.60	3.51	2.92
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	67.44	5.42	3.01	1.20
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	40.39	4.75	3.56	2.38
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	70.69	7.63	5.59	4.07
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	70.04	2.55	2.55	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	57.82	3.18	3.81	1.27
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	63.87	6.04	5.18	1.29
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	71.76	2.96	3.60	2.96
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	55.68	6.67	1.74	1.45
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	59.52	6.61	1.89	1.89
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	56.79	5.42	2.71	2.54
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	60.23	11.58	2.32	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	57.04	4.23	4.23	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	68.61	7.29	4.07	1.72
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	57.76	6.62	3.61	1.80
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	85.29	7.29	2.92	3.64
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	73.56	6.21	3.68	1.38
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	33.15	7.65	2.55	2.55
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	76.78	5.34	3.56	1.27
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	70.40	4.34	3.10	2.06
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	56.30	3.67	3.37	1.53
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	74.09	5.74	1.43	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	60.76	5.32	3.10	2.44
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	44.25	0.00	4.58	1.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	67.57	5.54	4.98	1.11
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	61.96	3.18	3.18	0.26
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	55.24	5.82	2.91	3.63
Astrocyte - cerebellum, donor1	11500-119F6	50.85	5.53	2.58	4.79
Astrocyte - cerebellum, donor2	11580-120F5	35.43	2.74	2.40	4.28
Astrocyte - cerebellum, donor3	11661-122F5	34.82	2.10	1.26	4.40
Astrocyte - cerebral cortex, donor1	11235-116D2	101.09	4.18	1.74	4.53
Astrocyte - cerebral cortex, donor2	11316-117D2	67.62	5.01	3.24	4.69
Astrocyte - cerebral cortex, donor3	11392-118C6	63.09	6.41	3.58	4.33
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	101.04	6.42	8.72	3.67
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	108.37	7.52	6.64	3.13
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	104.58	9.33	8.42	2.96
Basophils, donor1	12241-129G9	119.52	17.26	10.46	2.09
Basophils, donor2	12242-129H1	208.18	19.84	18.40	4.69
Basophils, donor3	12243-129H2	72.47	13.08	19.40	1.62
Bronchial Epithelial Cell, donor1	11511-119G8	34.07	3.45	2.16	1.29
Bronchial Epithelial Cell, donor2	11591-120G7	11.43	3.20	4.11	0.91
Bronchial Epithelial Cell, donor3	11672-122G7	50.21	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	50.21	3.77	4.39	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	32.02	4.78	5.61	1.66
Bronchial Epithelial Cell, donor6	11461-119B3	85.90	4.61	3.68	3.22
Bronchial Epithelial Cell, donor7	11769-123I5	82.23	4.86	3.42	1.26
Burkitt's lymphoma cell line:DAUDI	10422-106C8	134.49	13.71	11.03	2.06
Burkitt's lymphoma cell line:RAJI	10476-106I8	144.87	8.85	10.25	10.01
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	74.51	14.39	26.86	5.44
CD133+ stem cells - cord blood derived, pool1	12223-129E9	124.10	10.34	20.68	0.00
CD14+ Monocytes, donor1	11224-116B9	46.78	6.20	9.02	1.13
CD14+ Monocytes, donor2	11305-117B9	46.59	7.42	12.44	0.93
CD14+ Monocytes, donor3	11381-118B4	50.27	8.34	11.42	0.66
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	71.33	2.26	1.70	0.85
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	56.48	2.65	1.90	0.76
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	52.27	3.94	2.96	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	59.41	9.40	3.76	0.87
CD14+ monocytes - mock treated, donor2	11873-125C1	55.22	7.24	3.92	1.51
CD14+ monocytes - mock treated, donor3	11883-125D2	69.41	7.82	6.16	1.66
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	50.72	8.87	6.19	1.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	58.79	9.11	5.80	0.83
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	78.84	13.39	4.46	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	50.32	7.64	4.31	0.78
CD14+ monocytes - treated with BCG, donor2	11870-125B7	59.11	6.77	3.92	1.25
CD14+ monocytes - treated with BCG, donor3	11880-125C8	110.99	13.71	4.35	2.39
CD14+ monocytes - treated with Candida, donor1	11868-125B5	47.06	6.09	7.02	0.94
CD14+ monocytes - treated with Candida, donor2	11878-125C6	55.44	9.50	4.75	2.64
CD14+ monocytes - treated with Candida, donor3	11888-125D7	54.36	9.98	2.22	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	51.47	9.97	5.06	1.04
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	65.25	7.58	3.19	0.40
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	129.29	13.74	5.00	1.25
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	53.76	8.01	5.03	0.69
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	78.04	11.08	4.07	2.71
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	53.68	14.40	2.18	0.87
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	56.22	11.03	4.84	0.81
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	61.93	8.20	5.23	0.52
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	61.02	10.94	4.21	2.10
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	53.46	7.72	4.41	1.47
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	73.98	7.40	3.17	1.76
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	69.76	8.34	3.51	1.75
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	43.77	8.89	4.01	0.70
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	51.29	7.81	7.43	1.12
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	105.40	15.09	4.74	1.08
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	44.63	6.14	3.28	1.64
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	77.42	10.20	4.64	2.32
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	100.68	9.74	3.71	0.70
CD14+CD16+ Monocytes, donor1	11789-124B7	98.74	8.06	5.45	0.87
CD14+CD16+ Monocytes, donor2	11801-124D1	86.62	10.16	10.39	1.15
CD14+CD16+ Monocytes, donor3	11912-125G4	97.69	7.80	8.45	2.17
CD14+CD16- Monocytes, donor1	11788-124B6	89.85	10.43	9.34	0.93
CD14+CD16- Monocytes, donor2	11799-124C8	80.86	11.18	9.26	1.05
CD14+CD16- Monocytes, donor3	11910-125G2	95.88	12.26	6.02	1.78
CD14-CD16+ Monocytes, donor1	11790-124B8	95.95	10.46	9.19	1.28
CD14-CD16+ Monocytes, donor2	11800-124C9	99.24	9.88	9.44	1.32
CD14-CD16+ Monocytes, donor3	11911-125G3	127.17	9.69	4.21	1.05
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	105.68	10.16	18.29	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	80.00	8.14	12.20	1.36
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	74.56	10.36	6.21	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	101.81	15.46	10.66	1.07
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	99.17	11.79	11.26	0.54
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	85.64	8.42	4.91	1.40
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	81.57	12.55	10.20	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	102.83	6.59	5.27	0.00
CD19+ B Cells, donor1	11544-120B5	140.54	25.48	45.20	2.47
CD19+ B Cells, donor2	11624-122B4	121.15	17.41	32.64	0.73
CD19+ B Cells, donor3	11705-123B4	102.48	18.17	24.23	0.50
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	365.27	11.31	8.49	1.21
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	319.59	9.99	5.99	3.20
CD34+ Progenitors, donor1	11545-120B6	60.24	15.06	23.09	3.01
CD34+ Progenitors, donor2	11625-122B5	116.29	29.78	49.44	7.30
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	86.80	8.64	15.78	3.38
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	85.46	13.08	16.23	6.09
CD4+ T Cells, donor1	11225-116C1	194.60	18.57	36.06	5.36
CD4+ T Cells, donor2	11306-117C1	135.33	12.25	39.80	4.29
CD4+ T Cells, donor3	11382-118B5	140.60	14.33	32.63	1.52
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	67.38	8.68	10.46	1.02
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	76.81	8.53	13.03	1.57
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	70.72	6.61	14.09	1.44
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	97.19	6.64	39.82	3.79
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	100.43	9.83	28.80	3.51
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	79.11	6.59	13.18	3.30
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	85.41	5.35	11.56	2.46
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	70.50	5.76	14.07	2.20
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	68.35	5.16	12.09	0.64
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	130.45	8.07	30.04	0.90
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	104.12	6.99	25.85	3.14
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	119.67	10.12	19.80	1.32
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	72.10	13.49	17.71	0.84
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	56.72	6.65	9.77	1.45
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	61.48	6.01	15.70	0.33
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	92.46	5.44	24.47	3.26
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	103.97	5.36	29.48	2.68
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	100.42	8.97	21.52	5.38
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	87.89	10.94	15.76	1.48
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	86.21	7.80	13.86	1.73
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	87.84	8.83	14.92	1.05
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	114.27	7.08	22.25	5.56
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	116.11	9.96	26.43	3.03
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	145.56	14.38	17.87	2.18
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	99.47	9.40	14.85	2.47
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	90.47	10.16	12.92	0.92
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	118.64	5.58	9.77	4.19
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	110.77	6.92	18.83	4.15
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	99.14	9.08	13.01	1.96
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	103.18	9.24	12.32	3.08
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	100.63	7.52	9.67	1.79
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	91.41	2.77	12.46	2.77
CD8+ T Cells, donor1	11226-116C2	161.08	21.94	28.48	3.93
CD8+ T Cells, donor2	11307-117C2	137.03	18.77	24.03	2.25
CD8+ T Cells, donor3	11383-118B6	146.19	17.17	33.33	3.79
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	79.60	4.13	6.19	19.04
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	80.28	4.79	6.23	19.17
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	88.92	4.92	4.10	20.25
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	127.29	7.51	6.90	22.82
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	75.11	7.92	4.32	20.16
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	80.27	7.96	4.09	18.65
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	79.31	5.65	4.35	17.82
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	80.80	7.37	4.47	15.27
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	79.27	5.63	7.50	14.07
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	97.51	6.64	5.43	20.83
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	95.87	6.10	5.23	19.75
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	94.58	8.79	3.46	20.78
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	73.98	5.25	3.94	12.26
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	62.85	2.73	4.10	10.02
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	61.91	8.20	2.98	6.71
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	85.00	7.20	7.92	23.05
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	76.82	4.60	5.47	20.14
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	76.13	6.60	4.48	16.97
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	100.46	5.07	5.07	17.75
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	83.04	5.84	5.23	20.91
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	75.98	8.34	4.17	16.03
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	91.41	4.21	4.97	19.89
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	87.89	9.06	3.15	17.73
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	81.69	7.56	6.81	17.40
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	179.06	4.01	8.03	25.69
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	156.67	6.29	2.80	25.18
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	166.29	9.02	5.01	22.04
Cardiac Myocyte, donor1	11525-119I4	109.66	5.48	1.83	1.83
Cardiac Myocyte, donor2	11605-120I3	57.81	3.46	1.48	1.98
Cardiac Myocyte, donor3	11686-122I3	117.23	4.31	1.89	2.00
Chondrocyte - de diff, donor1	11261-116G1	117.17	3.81	4.51	5.20
Chondrocyte - de diff, donor2	11338-117F6	98.44	7.11	3.20	3.91
Chondrocyte - de diff, donor3	11410-118E6	71.57	5.01	3.64	2.39
Chondrocyte - re diff, donor2	11339-117F7	147.72	7.16	6.27	9.85
Chondrocyte - re diff, donor3	11411-118E7	75.22	4.85	1.21	2.43
Ciliary Epithelial Cells, donor1	11242-116D9	89.17	5.28	4.71	4.25
Ciliary Epithelial Cells, donor2	11323-117D9	67.12	5.34	2.57	3.42
Ciliary Epithelial Cells, donor3	11399-118D4	58.76	4.96	2.21	4.87
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	64.92	5.78	7.70	7.79
Corneal Epithelial Cells, donor1	11526-119I5	32.50	4.83	2.63	0.88
Corneal Epithelial Cells, donor2	11606-120I4	31.85	6.83	3.41	2.28
Corneal Epithelial Cells, donor3	11687-122I4	47.80	4.60	5.37	1.79
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	69.84	3.80	2.64	1.16
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	78.85	2.84	2.84	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	51.76	0.00	3.45	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	43.95	3.35	0.97	0.65
Dendritic Cells - plasmacytoid, donor1	11228-116C4	71.40	7.17	28.01	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	84.22	11.75	35.91	0.65
Dendritic Cells - plasmacytoid, donor3	11385-118B8	70.66	8.23	34.84	0.97
Endothelial Cells - Aortic, donor0	11207-116A1	82.88	13.34	6.00	6.84
Endothelial Cells - Aortic, donor1	11263-116G3	77.45	8.80	4.69	2.35
Endothelial Cells - Aortic, donor2	11340-117F8	72.40	10.18	5.37	5.37
Endothelial Cells - Aortic, donor3	11412-118E8	59.37	11.01	4.72	2.75
Endothelial Cells - Artery, donor1	11264-116G4	52.36	9.89	3.20	2.91
Endothelial Cells - Artery, donor2	11341-117F9	45.41	12.00	4.71	2.82
Endothelial Cells - Artery, donor3	11413-118E9	61.01	7.71	5.79	3.51
Endothelial Cells - Lymphatic, donor1	11236-116D3	52.75	7.31	0.89	2.44
Endothelial Cells - Lymphatic, donor2	11317-117D3	45.34	8.52	1.83	1.83
Endothelial Cells - Lymphatic, donor3	11393-118C7	49.61	7.05	0.85	2.54
Endothelial Cells - Microvascular, donor1	11265-116G5	45.16	10.40	4.75	4.75
Endothelial Cells - Microvascular, donor2	11342-117G1	109.34	6.77	5.73	3.64
Endothelial Cells - Microvascular, donor3	11414-118F1	22.26	5.10	3.26	2.27
Endothelial Cells - Thoracic, donor1	11266-116G6	64.02	16.40	6.00	5.20
Endothelial Cells - Thoracic, donor2	11343-117G2	38.79	6.81	3.14	4.72
Endothelial Cells - Umbilical vein, donor1	11243-116E1	77.65	12.42	4.85	5.22
Endothelial Cells - Umbilical vein, donor2	11324-117E1	45.19	8.91	2.82	3.04
Endothelial Cells - Umbilical vein, donor3	11400-118D5	45.19	10.26	5.01	3.66
Endothelial Cells - Vein, donor1	11267-116G7	56.88	7.96	4.55	4.55
Endothelial Cells - Vein, donor2	11344-117G3	59.37	15.37	8.38	4.19
Endothelial Cells - Vein, donor3	11416-118F3	46.63	11.93	4.55	3.61
Eosinophils, donor1	12244-129H3	45.74	45.74	15.25	0.00
Eosinophils, donor2	12245-129H4	302.00	26.40	8.25	9.90
Eosinophils, donor3	12246-129H5	164.07	28.53	3.57	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	36.89	5.62	3.66	1.95
Esophageal Epithelial Cells, donor2	11587-120G3	41.60	2.08	2.08	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	105.91	6.16	3.28	0.82
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	59.56	4.93	1.09	0.77
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	139.00	6.39	2.71	3.14
Fibroblast - Aortic Adventitial, donor1	11245-116E3	130.01	6.43	4.00	2.79
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	76.97	3.68	1.91	0.27
Fibroblast - Aortic Adventitial, donor2	11326-117E3	61.38	3.90	2.53	1.48
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	76.68	2.63	1.84	0.26
Fibroblast - Aortic Adventitial, donor3	11401-118D6	84.71	4.65	2.99	2.33
Fibroblast - Cardiac, donor1	11268-116G8	102.52	4.08	3.63	3.63
Fibroblast - Cardiac, donor2	11345-117G4	111.42	4.55	1.52	2.27
Fibroblast - Cardiac, donor3	11417-118F4	59.62	5.84	1.73	2.37
Fibroblast - Cardiac, donor4	11452-119A3	58.20	3.64	3.33	1.52
Fibroblast - Cardiac, donor5	11456-119A7	72.21	4.95	3.05	4.31
Fibroblast - Cardiac, donor6	11460-119B2	62.00	7.12	3.64	3.34
Fibroblast - Choroid Plexus, donor1	11492-119E7	62.98	6.57	2.28	4.02
Fibroblast - Choroid Plexus, donor2	11572-120E6	70.75	3.45	2.59	1.73
Fibroblast - Choroid Plexus, donor3	11653-122E6	71.77	5.86	4.39	1.46
Fibroblast - Conjunctival, donor1	11531-120A1	90.87	7.84	5.54	3.92
Fibroblast - Conjunctival, donor3	11692-122I9	88.53	3.56	5.77	4.41
Fibroblast - Dermal, donor1	11269-116G9	71.61	3.99	1.88	2.35
Fibroblast - Dermal, donor2	11346-117G5	107.54	8.96	5.66	6.60
Fibroblast - Dermal, donor3	11418-118F5	67.45	5.80	3.63	2.66
Fibroblast - Dermal, donor4	11450-119A1	81.39	6.56	3.62	3.62
Fibroblast - Dermal, donor5	11454-119A5	86.01	6.28	5.06	3.49
Fibroblast - Dermal, donor6	11458-119A9	81.37	6.98	3.74	5.20
Fibroblast - Gingival, donor1	11237-116D4	90.79	3.54	3.12	2.71
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	129.95	3.14	2.88	3.41
Fibroblast - Gingival, donor2	11318-117D4	80.39	6.46	4.22	3.03
Fibroblast - Gingival, donor3	11394-118C8	72.52	5.12	3.00	2.51
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	103.89	5.19	2.08	3.12
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	68.72	2.64	1.59	1.23
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	103.83	5.77	5.46	2.81
Fibroblast - Gingival, donor6 (control)	11922-125H5	101.42	5.81	4.19	2.43
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	28.23	1.06	0.71	0.35
Fibroblast - Gingival, donor7 (control)	11924-125H7	116.85	5.26	4.53	3.07
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	106.08	5.32	4.23	3.00
Fibroblast - Gingival, donor8 (control)	11926-125H9	147.76	4.94	5.37	3.95
Fibroblast - Gingival, donor9 (control)	11927-125I1	120.77	4.99	3.67	2.93
Fibroblast - Lung, donor1	11270-116H1	65.25	2.72	0.00	4.08
Fibroblast - Lung, donor2	11347-117G6	110.42	2.98	4.48	7.46
Fibroblast - Lung, donor3	11419-118F6	69.01	5.70	3.59	3.80
Fibroblast - Lymphatic, donor1	11506-119G3	51.65	5.00	6.66	5.00
Fibroblast - Lymphatic, donor2	11586-120G2	32.17	4.20	0.00	4.20
Fibroblast - Lymphatic, donor3	11667-122G2	14.83	2.24	1.40	1.96
Fibroblast - Mammary, donor1	11540-120B1	78.76	10.15	5.68	7.71
Fibroblast - Mammary, donor2	11620-122A9	39.94	3.99	3.99	0.00
Fibroblast - Mammary, donor3	11701-123A9	65.52	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	109.01	5.63	4.46	2.52
Fibroblast - Periodontal Ligament, donor2	11319-117D5	71.59	7.13	4.70	3.64
Fibroblast - Periodontal Ligament, donor3	11395-118C9	83.23	4.28	2.45	2.14
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	99.99	1.91	2.29	1.91
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	107.73	2.97	2.70	2.16
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	68.19	4.06	1.51	1.39
Fibroblast - Pulmonary Artery, donor1	11250-116E8	126.45	5.53	3.54	2.65
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	61.36	9.55	5.89	3.25
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	40.76	4.01	4.01	3.34
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	89.35	2.77	4.35	2.37
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	70.85	3.77	1.59	2.58
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	121.49	4.44	1.60	2.49
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	125.54	3.15	2.17	3.15
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	68.90	0.90	1.81	1.20
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	116.16	4.43	2.70	3.13
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	89.34	2.02	0.51	1.01
Fibroblast - skin normal, donor1	11553-120C5	122.57	3.28	1.97	2.79
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	91.83	1.40	3.01	1.20
Fibroblast - skin normal, donor2	11561-120D4	135.12	3.82	2.81	4.92
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	91.88	3.02	2.12	0.91
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	122.03	4.47	2.65	3.81
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	94.19	5.13	3.25	3.93
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	68.31	2.96	0.33	1.97
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	120.37	3.94	2.88	4.47
Fibroblast - skin walker warburg, donor1	11554-120C6	120.61	3.88	3.88	3.04
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	199.79	3.14	1.88	4.86
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	2348.94	0.00	0.00	22.16
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	62.75	3.49	1.74	1.74
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	91.71	3.99	1.73	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	75.21	5.20	3.12	1.82
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	70.01	5.11	2.04	2.81
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	107.18	7.66	3.83	22.20
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	120.60	9.57	4.47	16.59
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	174.58	10.27	5.42	18.54
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	67.01	7.17	2.76	17.92
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	67.58	3.88	2.05	14.16
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	94.11	7.13	3.37	14.46
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	65.03	8.19	2.38	17.71
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	67.19	7.50	1.96	14.68
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	135.76	10.61	3.98	20.78
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	83.10	7.35	2.54	5.51
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	69.21	4.31	2.59	7.63
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	74.14	4.03	2.69	7.25
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	66.04	5.33	1.49	5.82
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	58.69	5.81	2.08	7.34
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	69.12	3.25	2.24	6.71
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	54.08	2.74	1.60	5.48
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	53.07	4.61	1.37	6.35
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	54.43	4.37	1.75	5.68
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	66.48	5.61	3.84	2.66
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	57.07	6.68	2.07	4.13
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	60.99	5.59	1.12	5.14
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	58.07	5.24	2.22	4.03
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	71.08	8.65	3.05	5.09
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	73.33	5.05	1.95	5.76
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	59.52	5.41	2.19	5.41
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	67.80	3.59	2.56	4.27
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	56.54	6.09	2.21	4.65
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	70.13	5.16	1.75	5.16
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	79.02	5.92	5.10	5.92
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	64.99	5.57	1.86	3.71
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	57.65	4.27	1.96	3.80
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	55.87	4.17	1.00	4.84
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	65.91	5.07	3.53	5.07
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	73.06	6.15	1.72	2.46
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	57.06	4.86	1.78	3.40
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	69.27	5.77	1.28	4.17
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	57.52	3.98	3.13	3.41
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	48.40	3.64	2.85	2.69
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	65.68	4.87	3.65	3.95
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	62.30	5.44	1.99	3.14
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	56.21	3.95	2.42	1.54
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	65.65	5.89	2.52	2.81
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	52.31	3.15	1.11	2.78
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	66.85	4.81	1.07	4.01
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	68.39	5.51	2.30	2.45
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	69.56	3.76	1.42	2.33
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	53.94	3.52	1.63	3.52
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	64.71	3.50	2.21	3.32
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	67.11	3.95	0.66	2.63
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	39.67	5.95	5.95	3.97
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	70.84	3.17	2.11	2.90
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	64.76	2.42	0.81	2.42
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	51.34	4.07	1.52	1.52
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	104.31	6.97	3.98	10.55
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	79.50	3.08	1.39	6.16
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	102.70	6.96	3.89	11.25
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	103.58	10.01	4.38	22.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	96.35	4.80	5.09	16.11
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	80.25	7.38	3.23	11.07
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	76.72	17.32	2.47	22.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	98.25	6.19	3.48	18.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	113.92	4.81	3.21	19.25
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	69.55	19.13	0.00	22.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	94.71	9.44	2.93	18.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	98.01	8.65	2.47	15.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	46.65	6.66	0.00	19.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	76.34	8.11	3.36	10.35
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	88.90	8.17	4.25	13.73
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	46.14	10.90	4.19	7.55
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	72.52	8.91	3.50	9.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	76.42	8.15	2.38	10.87
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	93.97	16.71	10.44	14.62
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	79.61	7.45	5.73	12.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	63.34	6.81	5.33	10.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	88.10	8.47	3.39	13.55
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	91.13	12.84	4.97	15.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	83.54	12.66	4.60	11.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	68.49	0.00	0.00	10.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	69.58	8.46	2.31	9.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	73.34	6.52	3.59	7.17
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	66.22	9.36	0.00	12.04
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	58.95	6.16	2.70	6.93
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	92.43	21.23	4.79	9.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	42.24	17.39	2.48	7.45
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	81.16	8.49	6.61	7.08
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	63.97	12.07	2.41	4.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	63.58	11.19	2.54	9.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	65.41	15.55	3.99	5.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	87.82	8.88	5.43	6.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	88.53	10.62	4.72	9.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	75.26	6.42	3.50	7.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	100.07	6.58	3.07	2.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	78.84	19.50	5.09	2.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	79.39	10.15	1.79	8.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	78.12	10.68	4.85	5.34
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	90.16	2.28	2.28	3.42
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	50.73	2.49	1.25	3.33
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	109.07	1.12	5.62	2.25
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	70.41	4.76	1.59	1.59
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	71.43	1.67	1.25	1.25
Hep-2 cells mock treated, biol_rep1	11898-125E8	75.43	11.02	7.89	2.55
Hep-2 cells mock treated, biol_rep2	11899-125E9	80.86	15.02	5.57	4.56
Hep-2 cells mock treated, biol_rep3	11900-125F1	77.12	12.51	6.60	3.87
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	77.50	12.24	7.65	3.17
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	81.88	12.68	7.31	3.22
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	75.56	14.21	4.31	1.72
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	80.82	11.33	9.71	3.36
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	86.46	13.72	6.69	2.74
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	84.26	7.05	5.13	3.52
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	23.50	9.51	3.92	3.92
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	35.06	4.76	2.16	1.30
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	63.45	7.93	2.64	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	60.32	4.59	3.88	4.23
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	44.32	2.91	3.63	2.18
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	112.25	4.72	2.80	5.07
Hepatocyte, donor1	11523-119I2	54.48	2.42	6.05	0.00
Hepatocyte, donor2	11603-120I1	70.03	9.70	4.31	2.15
Hepatocyte, donor3	11684-122I1	52.15	4.91	3.07	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	102.47	20.89	26.76	3.26
Intestinal epithelial cells (polarized), donor1	11246-116E4	132.48	8.39	4.19	0.87
Iris Pigment Epithelial Cells, donor1	11530-119I9	73.41	3.57	2.47	3.43
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	101.88	3.18	9.55	3.18
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	133.51	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	27.08	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	76.14	8.31	4.15	1.38
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	105.11	0.00	5.01	2.50
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	94.95	11.87	35.60	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	82.01	15.38	15.38	7.69
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	95.99	13.71	4.57	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	84.47	6.50	6.50	3.25
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	73.36	30.01	10.00	3.33
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	79.87	3.63	7.26	14.52
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	103.23	18.53	13.23	2.65
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	86.47	16.63	9.98	3.33
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	120.48	31.43	10.48	5.24
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	108.97	17.64	10.71	3.78
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	80.42	20.11	7.73	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	175.62	73.17	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	93.03	14.86	8.40	3.23
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	80.50	9.66	9.66	1.61
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	71.69	11.95	11.95	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	89.64	7.33	8.96	2.44
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	71.79	8.40	5.46	2.10
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	86.23	14.37	28.74	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	105.28	8.84	8.04	4.82
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	81.25	4.62	7.39	2.77
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	30.16	15.08	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	77.89	8.02	6.61	1.89
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	84.35	8.16	3.63	0.91
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	88.45	0.00	0.00	14.74
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	82.86	17.22	6.46	4.30
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	87.66	7.62	6.35	2.54
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	98.58	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	81.62	11.48	8.29	2.55
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	60.15	1.82	10.94	1.82
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	63.22	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	110.68	10.00	7.85	2.86
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	73.00	9.95	19.91	3.32
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	92.91	9.26	5.86	1.54
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	86.05	7.02	5.27	1.76
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	110.01	18.86	9.43	6.29
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	63.28	10.43	8.34	3.48
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	95.16	2.21	13.28	6.64
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	87.53	6.48	6.48	3.24
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	75.86	6.10	2.62	4.36
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	112.49	2.25	6.75	13.50
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	104.54	6.97	10.45	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	119.48	6.40	5.33	7.47
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	80.36	9.70	5.54	2.77
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	68.39	8.55	11.40	2.85
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	69.95	4.60	4.60	5.52
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	124.04	3.03	0.00	6.05
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	136.59	6.21	0.00	6.21
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	82.47	4.23	6.34	3.17
Keratinocyte - epidermal, donor1	11272-116H3	43.25	3.18	2.94	0.49
Keratinocyte - epidermal, donor2	11349-117G8	96.04	5.86	1.17	0.59
Keratinocyte - epidermal, donor3	11421-118F8	77.33	6.72	3.60	1.33
Keratinocyte - oral, donor1	11251-116E9	102.73	6.58	5.45	1.70
Keratocytes, donor1	11527-119I6	158.85	5.16	3.44	8.94
Keratocytes, donor2	11607-120I5	51.56	10.55	5.86	0.00
Keratocytes, donor3	11688-122I5	111.25	1.78	2.17	1.58
Krukenberg tumor cell line:HSKTC	10687-109F3	193.42	30.77	6.59	0.00
Lens Epithelial Cells, donor1	11529-119I8	57.17	4.31	3.24	4.31
Lens Epithelial Cells, donor2	11609-120I7	77.50	3.69	3.23	3.58
Lens Epithelial Cells, donor3	11690-122I7	100.30	3.53	1.31	3.83
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	74.94	9.96	3.68	3.79
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	47.16	5.58	5.30	3.35
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	58.87	9.29	5.35	4.25
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	60.76	8.60	2.15	4.30
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	54.84	6.62	4.73	2.52
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	55.96	10.03	5.93	2.59
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	40.63	6.16	3.28	3.28
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	52.08	7.84	2.53	3.03
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	54.47	7.32	4.93	3.24
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	62.49	4.35	3.56	2.77
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	55.45	5.23	4.27	3.88
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	43.32	8.89	4.44	3.15
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	55.40	9.06	4.53	4.53
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	47.47	6.44	4.29	4.53
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	53.70	8.38	4.81	3.71
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	52.35	7.70	2.77	2.46
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	41.77	5.92	4.68	4.68
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	55.63	9.70	5.67	2.01
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	50.68	5.27	4.61	0.99
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	49.20	7.32	2.64	4.69
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	54.02	7.72	4.98	5.23
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	47.04	8.24	3.39	4.36
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	59.78	3.23	4.04	3.50
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	63.88	11.35	3.63	3.18
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	49.25	4.15	1.56	2.59
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	48.58	4.82	1.68	3.14
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	56.09	8.12	6.01	3.76
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	57.09	7.57	4.82	4.13
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	47.23	3.95	4.52	4.70
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	51.32	9.44	4.88	3.82
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	46.52	5.81	2.91	2.91
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	43.99	6.28	2.98	2.32
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	52.53	10.04	4.58	3.59
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	59.60	10.00	3.70	4.07
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	53.62	3.71	2.22	2.96
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	50.46	7.15	4.54	4.67
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	52.43	6.43	3.22	1.93
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	54.78	4.26	5.17	1.22
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	61.45	7.70	3.50	3.64
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	60.80	8.18	2.13	2.13
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	41.69	3.88	3.39	3.88
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	48.86	6.38	6.07	3.58
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	53.72	7.16	3.58	3.58
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	45.41	3.59	2.61	1.63
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	51.09	10.36	4.71	4.47
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	74.87	7.80	3.59	3.71
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	40.21	6.66	3.33	4.10
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	59.97	8.65	4.48	5.07
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	129.16	9.06	9.06	2.27
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	110.47	13.81	6.90	1.53
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	123.95	7.42	8.91	2.23
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	119.75	8.46	10.58	2.12
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	105.50	8.44	14.07	2.11
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	129.82	11.21	9.34	3.74
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	104.08	7.21	6.18	1.03
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	136.79	9.52	7.14	2.38
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	120.79	10.18	8.14	2.26
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	115.46	9.31	8.14	2.04
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	122.45	9.45	7.65	1.35
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	126.14	10.57	10.03	2.71
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	120.16	10.78	10.78	3.59
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	103.74	7.76	7.76	2.47
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	129.93	9.33	6.66	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	115.12	11.72	7.64	2.55
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	121.93	9.61	7.74	1.07
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	133.02	10.77	9.45	2.27
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	116.58	7.36	4.91	1.84
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	136.18	11.42	3.26	2.45
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	121.61	8.95	5.83	1.87
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	116.87	10.93	10.65	2.24
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	140.13	11.33	9.27	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	131.22	12.19	11.03	4.06
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	108.51	10.46	9.86	2.69
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	116.74	10.51	4.43	1.66
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	118.42	13.08	10.96	1.77
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	111.00	11.06	7.38	4.43
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	138.15	9.21	10.36	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	137.38	9.98	9.59	3.84
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	116.62	5.66	9.62	3.40
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	140.30	11.49	8.20	2.46
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	98.06	11.30	5.42	3.16
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	133.57	7.90	11.49	1.44
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	146.39	12.70	9.71	1.49
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	108.88	8.18	10.40	2.60
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	100.79	6.03	5.17	1.72
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	129.30	7.71	3.43	2.57
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	122.28	12.66	7.66	2.67
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	106.79	8.45	9.65	1.21
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	117.31	12.80	3.55	2.13
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	115.15	7.91	6.19	2.41
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	107.35	3.22	3.76	1.07
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	116.49	9.43	5.39	1.35
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	114.83	8.15	8.15	2.22
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	133.74	17.44	9.30	5.81
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	100.49	8.46	4.23	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	107.24	5.20	6.00	2.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	125.75	8.72	5.81	0.73
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	152.54	9.20	6.13	2.30
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	135.65	10.36	7.40	1.97
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	119.50	9.41	9.41	3.76
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	117.66	14.08	8.55	2.01
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	129.33	9.46	6.31	3.60
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	125.64	10.33	13.77	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	146.52	10.24	4.90	3.56
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	132.95	10.95	7.04	1.96
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	120.07	12.53	5.28	1.32
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	138.03	19.20	10.90	3.11
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	134.77	10.06	5.69	2.63
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	116.29	10.06	6.15	3.91
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	138.23	12.81	5.30	1.32
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	139.24	9.64	7.71	1.93
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	134.18	8.10	6.58	2.03
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	121.12	10.09	5.77	4.33
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	117.67	10.34	3.98	3.98
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	99.65	13.37	7.29	1.82
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	119.66	9.68	6.23	4.15
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	135.28	10.64	6.08	1.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	140.98	11.88	8.78	4.65
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	105.81	7.86	6.05	2.42
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	124.23	8.56	5.39	3.17
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	120.48	9.60	11.19	2.67
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	135.05	8.62	14.94	1.72
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	144.50	4.63	6.17	3.60
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	121.66	10.61	7.78	2.83
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	115.77	4.54	9.08	1.70
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	134.79	4.99	8.32	3.74
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	140.95	8.61	7.83	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	119.00	8.77	7.93	1.67
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	117.09	7.90	7.90	1.39
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	123.10	10.70	7.36	2.01
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	137.94	12.30	6.42	3.74
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	138.20	7.68	7.68	4.04
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	129.40	4.59	3.67	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	120.92	9.78	2.67	1.78
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	127.65	10.83	5.13	2.85
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	131.91	6.14	13.80	1.53
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	148.28	7.11	7.11	2.74
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	137.20	4.45	3.56	2.23
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	161.69	9.36	3.38	3.38
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	140.58	2.65	8.62	2.65
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	133.03	10.39	2.08	6.24
Macrophage - monocyte derived, donor1	11232-116C8	57.89	1.60	1.60	0.23
Macrophage - monocyte derived, donor2	11313-117C8	63.68	2.75	1.47	0.55
Macrophage - monocyte derived, donor3	11389-118C3	52.43	2.62	2.49	0.52
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	99.30	7.43	5.84	2.12
Mallassez-derived cells, donor2	11929-125I3	114.88	5.70	2.06	0.95
Mallassez-derived cells, donor3	11930-125I4	130.37	10.29	3.89	1.81
Mammary Epithelial Cell, donor1	11273-116H4	156.44	5.08	4.09	3.39
Mammary Epithelial Cell, donor2	11350-117G9	118.43	4.92	2.03	1.45
Mammary Epithelial Cell, donor3	11422-118F9	48.64	4.24	2.49	1.00
Mast cell - stimulated, donor1	11487-119E2	137.62	12.88	7.46	1.36
Mast cell, donor1	11563-120D6	79.38	6.81	3.78	1.73
Mast cell, donor2	11565-120D8	110.55	4.46	2.97	1.19
Mast cell, donor3	11566-120D9	106.03	5.18	5.18	0.90
Mast cell, donor4	11567-120E1	90.59	6.74	5.32	1.42
Mast cell, expanded and stimulated, donor5	11940-126A5	98.69	7.98	4.10	1.22
Mast cell, expanded and stimulated, donor8	11942-126A7	164.01	4.67	8.76	4.67
Mast cell, expanded, donor5	11939-126A4	78.24	7.11	3.21	0.23
Mast cell, expanded, donor8	11941-126A6	78.16	8.37	4.35	1.67
Melanocyte - dark, donor1	11502-119F8	72.83	13.63	5.37	2.79
Melanocyte - dark, donor2	11582-120F7	71.64	4.15	1.04	3.46
Melanocyte - dark, donor3	11663-122F7	101.56	6.37	3.91	1.45
Melanocyte - light, donor1	11274-116H5	35.50	4.23	0.71	0.00
Melanocyte - light, donor2	11351-117H1	29.35	4.78	4.78	1.36
Melanocyte - light, donor3	11423-118G1	32.09	6.07	0.87	0.87
Melanocyte, donor1 (MC+1)	12641-134G4	82.68	7.08	2.39	0.83
Melanocyte, donor2 (MC+2)	12739-135I3	66.16	5.38	3.77	1.08
Melanocyte, donor3 (MC+3)	12837-137B2	54.64	9.64	3.75	0.54
Meningeal Cells, donor1	11493-119E8	67.74	6.82	3.10	9.18
Meningeal Cells, donor2	11573-120E7	60.74	9.24	1.32	7.04
Meningeal Cells, donor3	11654-122E7	94.62	5.95	3.50	5.46
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	108.07	5.13	3.71	3.42
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	89.97	7.04	3.42	2.31
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	15.77	1.31	0.00	2.63
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	27.47	1.31	5.23	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	81.09	7.18	3.59	2.15
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	88.52	3.60	1.91	2.54
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	84.95	4.52	1.01	4.02
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	67.68	5.05	5.93	3.30
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	75.25	5.11	5.84	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	54.83	5.52	5.32	3.27
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	90.45	2.08	1.80	3.19
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	30.85	3.35	1.49	1.86
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	86.97	5.13	3.03	1.84
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	38.87	2.08	2.97	1.78
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	51.38	0.00	2.34	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	58.92	4.48	1.92	1.92
Mesenchymal stem cells - adipose, donor0	11217-116B2	133.98	8.15	3.90	1.42
Mesenchymal stem cells - hepatic, donor0	11218-116B3	96.01	2.81	1.88	2.81
Mesenchymal stem cells - umbilical, donor0	11214-116A8	119.01	7.26	2.90	3.63
Mesothelial Cells, donor1	11247-116E5	82.73	6.10	2.39	1.59
Mesothelial Cells, donor2	12156-128G5	76.57	3.50	4.00	2.00
Mesothelial Cells, donor3	11402-118D7	50.87	4.62	2.67	0.87
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	44.56	8.10	2.70	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	82.99	5.91	3.20	1.23
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	62.13	4.42	5.30	0.59
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	6.91	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	64.16	4.34	3.41	0.62
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	41.90	3.32	1.66	0.83
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	18.53	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	68.82	3.50	3.75	1.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	47.48	4.65	4.19	1.86
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	19.47	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	51.62	3.86	2.24	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	40.78	6.34	2.77	0.79
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	17.10	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	49.56	1.77	3.54	0.88
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	61.17	2.66	3.04	0.38
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	18.42	0.00	0.00	1.32
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	54.33	4.88	1.91	0.21
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	20.26	0.92	1.84	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	32.49	5.37	1.19	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	20.12	5.03	0.00	1.68
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	53.44	3.76	3.01	0.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	35.65	4.75	3.57	0.71
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	22.67	2.21	1.11	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	50.65	5.07	3.91	0.46
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	44.59	3.16	3.16	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	37.10	3.47	3.47	0.20
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	53.21	4.72	2.36	0.43
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	29.34	1.78	2.22	0.89
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	47.09	5.26	2.41	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	22.31	3.55	2.03	0.51
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	13.26	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	58.16	2.72	2.72	0.27
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	35.88	5.00	2.65	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	21.81	2.18	2.18	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	49.98	4.32	3.36	0.96
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	44.43	3.60	2.40	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	24.68	2.74	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	61.57	3.50	2.50	1.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	53.89	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	16.31	0.00	4.08	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	67.00	3.50	2.19	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	36.42	6.62	0.00	1.10
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	24.98	3.84	0.64	1.28
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	82.31	5.95	4.46	0.99
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	29.23	2.78	2.09	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	13.26	0.00	4.42	4.42
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	60.85	6.15	1.71	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	27.57	3.50	1.75	0.44
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	32.31	2.84	0.36	0.36
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	70.98	5.61	3.65	0.84
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	29.09	3.33	3.33	0.83
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	27.39	4.08	1.17	0.58
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	47.96	3.32	2.11	0.90
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	51.34	4.59	4.59	0.83
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	28.88	7.22	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	44.33	4.62	1.85	1.85
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	56.91	5.69	1.71	1.71
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	36.89	3.32	1.24	0.55
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	55.20	4.41	2.07	1.04
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	42.04	3.43	1.29	0.86
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	20.96	2.54	1.27	0.64
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	41.90	3.47	0.80	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	62.56	3.59	1.20	1.20
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	32.63	2.40	0.71	0.42
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	58.61	4.14	1.27	0.96
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	68.33	4.86	2.21	1.55
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	29.20	5.31	0.76	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	68.75	3.69	2.56	0.85
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	66.86	3.20	1.72	0.98
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	26.72	2.61	0.65	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	53.81	2.94	0.88	0.88
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	65.16	3.46	2.59	0.86
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	64.29	3.30	1.65	0.82
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	60.15	2.38	1.49	1.19
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	45.20	18.83	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	51.69	1.78	1.78	1.78
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	50.93	9.53	3.61	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	56.81	8.42	2.10	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	49.62	6.92	5.73	0.20
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	50.29	10.24	0.93	1.86
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	78.49	5.63	3.38	2.63
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	54.07	6.13	3.46	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	67.75	6.45	2.49	0.11
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	36.10	8.10	2.95	2.21
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	37.01	7.33	3.66	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	40.45	12.44	3.11	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	90.85	13.90	2.14	1.07
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	30.91	19.32	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	33.33	6.06	2.02	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	48.91	8.85	5.90	0.84
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	72.18	29.96	8.17	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	94.10	11.44	6.36	1.27
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	83.41	18.63	6.48	0.81
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	43.80	10.57	3.02	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	108.49	11.42	5.71	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	182.70	6.52	3.26	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	109.31	9.50	0.00	4.75
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	75.29	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	135.94	6.89	3.02	3.66
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	104.52	3.66	2.09	5.23
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	43.39	3.34	0.67	2.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	24.62	0.83	0.42	1.25
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	200.41	4.18	1.33	5.32
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	94.16	15.96	6.38	4.79
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	19.72	2.72	2.72	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	271.97	12.86	1.84	11.03
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	18.42	4.60	1.67	2.93
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	50.67	4.65	1.86	1.63
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	25.67	2.16	0.81	1.35
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	56.76	4.41	1.47	1.68
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	456.52	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	33.75	3.47	1.99	3.97
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	86.07	2.44	0.54	3.79
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	30.60	2.72	0.68	0.91
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	32.66	2.12	1.63	2.12
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	54.68	3.65	1.09	1.46
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	29.70	4.77	0.53	1.59
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	24.01	4.20	1.20	1.80
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	219.88	2.95	1.64	5.25
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	20.82	1.95	0.81	0.81
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	53.27	3.00	1.76	1.94
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	25.32	4.92	2.11	2.11
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	28.50	0.92	2.30	2.30
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	33.42	2.57	0.96	1.61
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	220.04	5.17	0.69	2.76
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	424.78	17.70	0.00	10.11
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	48.34	3.79	1.11	2.23
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	30.91	3.39	1.27	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	58.63	2.37	0.47	2.37
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	35.20	5.15	1.72	1.29
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	451.39	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	33.66	3.00	1.33	1.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	50.05	3.16	0.90	0.90
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	38.89	3.97	2.38	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	32.50	1.86	0.93	1.86
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	62.05	6.43	1.89	1.89
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	28.68	3.58	3.26	0.98
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	18.74	1.31	1.74	0.87
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	63.32	4.07	0.00	3.62
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	30.87	0.88	0.88	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	25.26	3.99	0.00	1.33
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	34.72	1.98	1.49	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	25.27	2.30	1.15	0.77
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	74.40	1.21	0.00	1.21
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	69.18	5.75	1.77	3.09
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	33.21	4.07	0.00	2.03
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	316.79	10.22	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	28.66	3.66	0.61	0.61
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	28.64	2.20	1.26	0.63
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	21.79	3.03	0.30	0.91
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	39.56	3.16	0.79	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	307.22	5.67	0.00	3.40
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	429.92	15.17	0.00	5.06
Myoblast, donor1	11241-116D8	97.64	3.73	2.48	1.74
Myoblast, donor2	11322-117D8	73.07	3.64	2.88	2.49
Myoblast, donor3	11398-118D3	76.35	3.87	2.19	2.52
NK T cell leukemia cell line:KHYG-1	10777-110G3	441.01	29.92	15.61	10.80
Natural Killer Cells, donor1	11230-116C6	158.37	22.14	27.98	3.08
Natural Killer Cells, donor2	11311-117C6	135.70	20.81	24.12	3.32
Natural Killer Cells, donor3	11387-118C1	140.43	16.75	28.16	2.21
Neural stem cells, donor1	11275-116H6	112.51	5.08	2.18	5.81
Neural stem cells, donor2	11352-117H2	78.95	9.63	3.85	7.70
Neurons, donor1	11494-119E9	159.31	13.65	14.79	7.97
Neurons, donor2	11574-120E8	116.25	4.62	6.83	5.50
Neurons, donor3	11655-122E8	154.57	15.62	7.40	12.33
Neutrophils, donor1	11233-116C9	167.97	7.42	2.78	0.93
Neutrophils, donor2	11314-117C9	95.66	0.00	2.90	0.00
Neutrophils, donor3	11390-118C4	196.69	6.11	3.05	2.44
Nucleus Pulposus Cell, donor1	11252-116F1	83.71	2.97	2.37	3.92
Nucleus Pulposus Cell, donor2	11409-118E5	46.24	2.60	3.91	2.28
Nucleus Pulposus Cell, donor3	11462-119B4	87.64	5.62	3.01	4.21
Olfactory epithelial cells, donor1	11933-125I7	51.89	3.72	1.65	3.03
Olfactory epithelial cells, donor2	11934-125I8	89.60	4.20	2.75	2.89
Olfactory epithelial cells, donor3	11935-125I9	73.32	4.20	2.04	2.27
Olfactory epithelial cells, donor4	11936-126A1	79.87	5.06	2.43	1.95
Oligodendrocyte - precursors, donor1	11496-119F2	113.14	7.82	3.01	3.01
Osteoblast - differentiated, donor1	11276-116H7	140.80	5.74	3.40	3.62
Osteoblast - differentiated, donor2	11353-117H3	51.44	4.57	0.00	1.14
Osteoblast - differentiated, donor3	11425-118G3	54.00	2.48	2.48	3.72
Osteoblast, donor1	11277-116H8	132.70	9.58	5.47	9.77
Osteoblast, donor2	11354-117H4	147.49	2.11	3.51	5.62
Osteoblast, donor3	11426-118G4	118.37	6.40	4.98	5.51
Pancreatic stromal cells, donor1	11249-116E7	90.81	4.04	2.95	2.78
Pericytes, donor1	11491-119E6	26.26	2.11	1.67	2.56
Pericytes, donor2	11571-120E5	26.71	2.94	1.13	3.17
Pericytes, donor3	11652-122E5	68.16	2.85	3.66	2.85
Perineurial Cells, donor1	11499-119F5	117.54	5.20	2.49	3.05
Perineurial Cells, donor2	11579-120F4	73.61	3.31	2.48	3.59
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	95.94	9.56	18.49	0.96
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	72.97	7.10	13.22	0.49
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	55.26	10.61	16.31	1.81
Placental Epithelial Cells, donor1	11278-116H9	92.56	4.54	2.63	0.48
Placental Epithelial Cells, donor2	11355-117H5	62.10	4.44	3.33	2.22
Placental Epithelial Cells, donor3	11427-118G5	41.82	6.48	3.73	3.93
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	77.21	5.70	1.90	1.58
Preadipocyte - breast, donor1	11467-119B9	98.48	5.82	2.25	2.06
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	72.57	1.31	1.17	0.13
Preadipocyte - breast, donor2	11328-117E5	78.58	5.18	2.93	1.80
Preadipocyte - omental, donor1	11468-119C1	90.79	4.69	1.92	2.13
Preadipocyte - omental, donor2	11329-117E6	80.75	4.80	1.31	0.87
Preadipocyte - omental, donor3	11403-118D8	91.11	6.02	3.15	1.29
Preadipocyte - perirenal, donor1	11469-119C2	56.10	4.92	0.98	0.98
Preadipocyte - subcutaneous, donor1	11279-116I1	99.20	5.22	2.15	2.46
Preadipocyte - subcutaneous, donor2	11356-117H6	93.67	5.49	3.90	3.90
Preadipocyte - subcutaneous, donor3	11428-118G6	101.83	7.32	5.11	2.38
Preadipocyte - visceral, donor1	11280-116I2	106.65	5.22	2.61	2.61
Preadipocyte - visceral, donor2	11357-117H7	65.81	3.68	2.76	1.38
Preadipocyte - visceral, donor3	11429-118G7	75.02	3.03	3.34	2.40
Prostate Epithelial Cells (polarized), donor1	11253-116F2	124.30	6.94	2.26	0.91
Prostate Epithelial Cells, donor2	11331-117E8	48.61	3.11	1.49	1.76
Prostate Epithelial Cells, donor3	11404-118D9	59.28	2.82	1.78	0.55
Prostate Stromal Cells, donor1	11254-116F3	149.32	3.53	3.99	3.64
Prostate Stromal Cells, donor2	11332-117E9	105.79	5.56	2.15	3.77
Prostate Stromal Cells, donor3	11405-118E1	80.19	3.65	2.92	2.92
Renal Cortical Epithelial Cells, donor1	11516-119H4	50.00	6.20	5.47	5.11
Renal Cortical Epithelial Cells, donor2	11596-120H3	85.05	3.40	2.15	1.66
Renal Epithelial Cells, donor1	11517-119H5	22.83	3.04	4.06	2.03
Renal Epithelial Cells, donor2	11597-120H4	27.74	5.69	3.56	4.98
Renal Epithelial Cells, donor3	11678-122H4	89.46	5.50	2.43	2.22
Renal Glomerular Endothelial Cells, donor1	11514-119H2	19.06	6.13	1.36	6.13
Renal Glomerular Endothelial Cells, donor2	11594-120H1	31.53	9.57	5.79	3.50
Renal Glomerular Endothelial Cells, donor3	11675-122H1	79.04	7.55	3.33	2.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	13.31	4.66	1.33	0.67
Renal Mesangial Cells, donor1	11518-119H6	51.50	5.50	4.18	5.50
Renal Mesangial Cells, donor2	11598-120H5	39.50	8.15	5.02	1.88
Renal Mesangial Cells, donor3	11679-122H5	25.24	3.33	2.50	2.22
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	66.30	9.39	5.10	4.83
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	45.54	5.48	3.80	2.53
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	39.34	6.17	4.05	3.47
Retinal Pigment Epithelial Cells, donor0	11215-116A9	95.67	2.85	3.11	2.07
Retinal Pigment Epithelial Cells, donor1	11528-119I7	52.02	5.40	2.56	3.13
Retinal Pigment Epithelial Cells, donor2	11608-120I6	37.05	2.06	2.06	1.03
Retinal Pigment Epithelial Cells, donor3	11689-122I6	105.63	4.01	4.77	5.27
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	70.69	3.07	1.60	1.20
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	176.00	8.93	5.36	8.93
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	296.10	7.71	0.00	12.11
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	219.84	9.86	3.48	6.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	125.86	7.02	2.86	6.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	83.62	6.36	3.08	4.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	134.40	7.92	3.90	5.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	166.96	8.31	4.71	3.97
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	98.48	7.11	5.01	3.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	115.33	9.71	4.39	4.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	91.18	5.07	3.15	5.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	91.52	6.20	4.99	6.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	130.99	6.63	3.40	5.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	106.44	7.03	3.16	3.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	94.54	5.58	4.72	5.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	119.93	6.86	4.43	5.31
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	112.60	9.18	2.68	6.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	92.88	6.43	3.54	4.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	137.17	7.89	4.13	6.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	114.13	8.63	3.58	5.31
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	93.74	5.74	5.26	4.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	119.35	6.49	4.58	3.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	107.97	8.86	4.27	5.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	88.86	5.33	4.20	4.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	106.81	8.20	5.30	3.93
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	107.03	7.48	2.73	5.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	77.01	6.87	4.29	5.03
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	107.19	9.00	6.31	4.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	118.17	9.20	4.48	5.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	89.88	7.94	3.97	3.97
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	119.96	9.35	8.42	5.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	108.03	9.95	2.70	3.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	99.10	9.73	5.53	3.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	97.55	10.44	5.22	3.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	100.00	10.23	4.17	5.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	97.92	8.51	5.28	5.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	95.24	7.13	5.40	5.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	115.03	6.53	3.95	3.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	92.73	7.68	3.43	3.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	107.70	7.39	4.27	4.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	81.47	6.31	2.39	5.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	85.67	4.59	3.99	4.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	97.02	8.80	2.67	4.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	122.37	5.81	2.21	7.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	79.29	6.67	3.33	3.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	92.91	6.45	2.02	4.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	89.65	6.78	4.99	5.93
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	143.24	5.59	3.84	6.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	119.68	7.25	3.32	4.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	111.49	6.73	2.69	5.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	241.62	10.33	6.40	7.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	202.00	7.91	5.48	7.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	123.27	7.84	3.92	7.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	133.22	7.24	4.07	7.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	145.58	7.79	2.70	8.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	158.10	6.73	1.65	6.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	132.76	5.98	1.71	8.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	188.11	7.81	1.80	7.21
Schwann Cells, donor1	11498-119F4	31.41	6.02	4.14	6.21
Schwann Cells, donor2	11578-120F3	54.44	3.40	6.80	6.80
Schwann Cells, donor3	11659-122F3	68.79	5.48	1.97	3.07
Sebocyte, donor1	11220-116B5	57.52	3.83	1.10	1.10
Sebocyte, donor2	11301-117B5	56.07	1.84	3.68	3.68
Sebocyte, donor3	11378-118B1	51.73	3.71	1.86	0.82
Sertoli Cells, donor1	11255-116F4	97.74	0.00	1.66	1.66
Sertoli Cells, donor2	11333-117F1	42.37	2.82	5.65	5.65
Skeletal Muscle Cells, donor1	11281-116I3	104.52	3.08	2.46	5.63
Skeletal Muscle Cells, donor2	11358-117H8	62.16	4.34	2.17	4.34
Skeletal Muscle Cells, donor3	11430-118G8	58.52	2.51	4.18	4.18
Skeletal Muscle Cells, donor4	11451-119A2	83.42	5.81	4.08	2.51
Skeletal Muscle Cells, donor5	11455-119A6	78.19	5.05	3.57	2.97
Skeletal Muscle Cells, donor6	11459-119B1	97.27	5.69	4.46	1.23
Skeletal Muscle Satellite Cells, donor1	11240-116D7	110.00	3.65	3.91	3.40
Skeletal Muscle Satellite Cells, donor2	11321-117D7	65.92	3.85	3.28	3.42
Skeletal Muscle Satellite Cells, donor3	11397-118D2	89.19	7.84	4.66	2.58
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	113.49	5.14	2.95	4.38
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	73.10	5.07	4.34	2.90
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	57.38	5.09	3.85	3.85
Skin - palm, donor1	10286-104F7	83.27	5.37	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	48.87	3.17	1.87	1.15
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	116.14	9.00	3.27	1.64
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	55.18	4.28	1.95	0.91
Small Airway Epithelial Cells, donor1	11256-116F5	129.56	2.64	2.64	2.50
Small Airway Epithelial Cells, donor2	11334-117F2	70.19	2.67	1.55	2.81
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	99.38	4.44	5.50	1.27
Small Airway Epithelial Cells, donor3	11406-118E2	55.46	3.22	2.02	1.20
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	153.37	4.01	2.16	7.10
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	56.92	1.56	1.33	0.22
Smooth Muscle Cells - Aortic, donor0	11210-116A4	94.05	6.47	7.05	3.53
Smooth Muscle Cells - Aortic, donor1	11283-116I5	73.81	4.86	2.65	2.65
Smooth Muscle Cells - Aortic, donor2	11360-117I1	97.66	6.30	2.76	2.76
Smooth Muscle Cells - Aortic, donor3	11432-118H1	95.03	9.27	4.64	2.32
Smooth Muscle Cells - Bladder, donor1	11519-119H7	60.05	3.00	3.00	4.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	87.70	6.52	3.19	2.93
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	102.85	8.42	3.10	1.77
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	138.66	5.63	3.71	3.20
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	83.03	1.95	1.30	1.95
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	81.21	4.73	1.77	1.77
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	53.24	1.85	1.28	0.85
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	36.93	2.44	1.63	1.30
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	87.07	2.13	2.13	1.52
Smooth Muscle Cells - Carotid, donor1	11285-116I7	93.95	5.81	2.78	3.54
Smooth Muscle Cells - Carotid, donor2	11362-117I3	79.57	0.00	12.24	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	78.20	2.38	1.91	3.81
Smooth Muscle Cells - Colonic, donor1	11239-116D6	92.91	2.80	2.21	2.36
Smooth Muscle Cells - Colonic, donor2	11320-117D6	70.17	3.66	2.15	1.72
Smooth Muscle Cells - Colonic, donor3	11396-118D1	74.84	4.20	3.67	2.62
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	108.43	5.41	4.33	3.25
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	74.37	1.08	3.23	1.08
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	62.46	2.39	1.79	1.49
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	41.31	4.78	3.76	2.39
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	80.49	3.30	3.46	2.75
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	97.52	4.23	2.62	1.61
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	81.01	5.01	4.32	1.37
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	69.44	6.04	3.62	2.42
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	164.25	7.95	3.71	4.50
Smooth Muscle Cells - Prostate, donor1	11257-116F6	111.32	4.26	3.06	4.66
Smooth Muscle Cells - Prostate, donor2	11335-117F3	97.17	3.76	3.38	3.26
Smooth Muscle Cells - Prostate, donor3	11465-119B7	78.38	2.03	1.27	2.03
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	113.08	4.67	4.07	4.37
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	63.01	5.25	6.75	0.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	20.68	6.46	0.00	3.88
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	93.48	6.05	4.19	2.33
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	87.34	4.04	2.02	1.01
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	73.65	5.33	2.82	1.25
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	36.87	3.83	1.47	0.88
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	111.30	4.92	3.58	3.33
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	56.06	2.34	3.74	2.80
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	104.63	6.33	4.32	2.88
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	86.17	9.43	5.10	3.06
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	72.96	4.89	3.95	5.26
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	110.54	5.87	4.61	2.79
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	121.74	3.10	2.43	2.35
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	27.14	0.48	1.90	0.48
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	92.97	6.61	3.91	3.18
Smooth Muscle Cells - Uterine, donor1	11258-116F7	113.79	5.74	3.09	3.09
Smooth Muscle Cells - Uterine, donor3	11466-119B8	88.65	5.85	3.22	1.46
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	63.75	1.55	0.97	1.94
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	64.53	2.38	0.79	0.53
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	118.65	3.72	0.74	0.74
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	91.99	2.16	0.72	2.52
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	76.65	3.41	2.84	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	127.61	6.70	1.18	3.54
Smooth muscle cells - airway, control, donor1	11966-126D4	86.34	4.32	1.02	2.54
Smooth muscle cells - airway, control, donor2	11967-126D5	65.49	1.60	0.80	3.99
Smooth muscle cells - airway, control, donor3	11968-126D6	74.40	2.51	0.42	1.25
Smooth muscle cells - airway, control, donor4	11969-126D7	100.84	2.75	1.38	2.75
Synoviocyte, donor1	11291-117A4	130.28	5.39	3.70	2.52
Synoviocyte, donor2	11368-117I9	64.54	5.87	3.35	1.51
Synoviocyte, donor3	11440-118H9	62.33	3.13	2.68	0.67
Trabecular Meshwork Cells, donor1	11532-120A2	54.31	8.58	4.29	6.07
Trabecular Meshwork Cells, donor2	11612-122A1	21.80	5.95	1.98	3.96
Trabecular Meshwork Cells, donor3	11693-123A1	40.06	4.17	3.70	2.55
Tracheal Epithelial Cells, donor1	11292-117A5	106.81	4.23	5.95	2.37
Tracheal Epithelial Cells, donor2	11369-118A1	46.39	7.34	4.64	2.32
Tracheal Epithelial Cells, donor3	11441-118I1	56.12	6.30	4.58	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	73.81	4.43	1.60	0.49
Urethra, donor2	10319-105A4	50.36	5.40	0.00	0.00
Urothelial Cells, donor1	11520-119H8	29.49	5.84	2.66	0.27
Urothelial Cells, donor2	11600-120H7	25.24	2.40	4.01	0.00
Urothelial Cells, donor3	11681-122H7	26.13	4.13	2.52	0.69
Urothelial cells, donor0	11216-116B1	76.90	4.01	3.34	0.67
Whole blood (ribopure), donor090309, donation1	12179-129A1	135.25	6.23	8.90	0.89
Whole blood (ribopure), donor090309, donation2	12180-129A2	154.40	18.58	10.01	1.43
Whole blood (ribopure), donor090309, donation3	12181-129A3	61.61	4.11	2.74	0.68
Whole blood (ribopure), donor090325, donation1	12176-128I7	99.86	4.48	5.85	0.69
Whole blood (ribopure), donor090325, donation2	12177-128I8	104.00	5.81	5.81	1.16
Whole blood (ribopure), donor090612, donation1	12182-129A4	104.12	4.16	2.08	4.16
Whole blood (ribopure), donor090612, donation2	12183-129A5	110.14	9.18	11.01	3.67
Whole blood (ribopure), donor090612, donation3	12184-129A6	50.21	1.83	7.30	0.00
Wilms' tumor cell line:G-401	10809-111A8	78.21	4.81	4.07	6.17
Wilms' tumor cell line:HFWT	10597-108E3	84.48	4.40	0.00	4.40
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	101.11	2.79	3.35	1.68
achilles tendon, donor2	10292-104G4	43.40	4.13	2.07	4.13
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	187.90	9.18	12.75	7.39
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	130.02	13.47	11.14	3.48
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	116.22	15.19	18.87	7.72
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	138.23	7.62	11.16	6.53
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	83.48	6.46	3.65	3.37
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	104.05	14.38	8.04	3.60
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	102.62	10.07	7.62	4.08
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	66.54	9.25	11.02	3.97
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	88.61	10.21	2.45	1.23
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	129.69	13.59	16.70	3.88
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	94.94	9.38	8.10	4.05
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	23.40	11.70	3.90	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	85.75	6.51	6.04	3.02
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	119.87	17.35	16.83	2.07
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	84.17	8.18	13.74	1.75
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	108.75	5.58	5.58	5.11
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	216.32	23.85	6.99	2.06
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	45.74	2.76	1.23	0.92
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	100.28	8.11	8.53	0.43
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	80.07	6.07	7.58	2.73
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	91.95	4.33	9.63	2.17
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	131.42	10.91	10.02	2.23
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	117.74	12.34	8.67	2.67
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	161.66	22.30	7.43	7.43
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	78.72	13.94	6.40	3.01
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	72.83	9.59	6.11	4.36
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	41.24	22.49	9.37	1.87
adenocarcinoma cell line:IM95m	10796-110I4	146.48	19.31	8.24	1.41
adipose tissue, adult, pool1	10010-101C1	46.07	3.88	2.48	0.93
adipose, donor1	10184-103D4	175.34	8.21	3.52	36.94
adipose, donor2	10185-103D5	47.04	0.41	2.03	8.11
adipose, donor3	10186-103D6	69.16	2.72	2.45	9.80
adipose, donor4	10187-103D7	66.74	8.67	1.73	12.13
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	177.39	5.52	5.68	7.42
adrenal gland, adult, pool1	10081-102A9	18.19	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	151.82	7.47	5.34	6.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	190.80	34.30	18.58	7.15
amniotic membrane cells, donor1	12235-129G3	60.74	10.20	3.01	0.46
amniotic membrane cells, donor2	12236-129G4	68.63	10.14	5.41	1.01
amniotic membrane cells, donor3	12237-129G5	47.14	7.37	4.12	0.88
amygdala - adult, donor10196	10167-103B5	80.63	5.93	0.00	2.37
amygdala, adult, donor10252	10151-102I7	69.75	4.66	2.43	1.01
amygdala, newborn, donor10223	10360-105E9	109.10	2.26	1.61	3.23
anaplastic carcinoma cell line:8305C	10428-106D5	72.96	2.80	1.27	1.40
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	154.22	16.55	9.05	3.31
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	143.97	7.01	4.01	8.68
aorta, adult, pool1	10052-101G7	44.91	2.16	0.78	1.57
appendix, adult	10189-103D9	57.05	5.05	3.88	1.16
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	150.30	31.30	11.01	3.78
artery, adult	10190-103E1	36.68	1.36	0.00	1.36
astrocytoma cell line:TM-31	10425-106D2	134.73	10.14	3.77	4.64
b cell line:RPMI1788	10427-106D4	88.03	3.27	4.61	2.68
basal cell carcinoma cell line:TE 354.T	10702-109G9	108.48	4.72	1.94	1.39
bile duct carcinoma cell line:HuCCT1	10432-106D9	109.85	12.90	6.75	3.87
bile duct carcinoma cell line:TFK-1	10496-107C1	112.81	7.03	5.19	1.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	87.24	6.71	7.27	3.36
bladder, adult, pool1	10011-101C2	67.25	2.17	2.72	1.09
blood, adult, pool1	10053-101G8	39.86	6.64	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	84.78	4.28	0.00	1.71
bone marrow, adult	10192-103E3	76.26	4.72	1.35	0.67
brain, adult, donor1	10084-102B3	32.80	4.10	1.03	0.00
brain, adult, pool1	10012-101C3	63.14	3.34	1.56	2.34
brain, fetal, pool1	10085-102B4	66.78	2.67	10.69	8.01
breast carcinoma cell line:MCF7	10482-107A5	140.74	9.58	6.28	4.29
breast carcinoma cell line:MDA-MB-453	10419-106C5	63.29	4.12	2.87	0.25
breast, adult, donor1	10080-102A8	34.72	3.16	0.63	3.79
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	164.64	5.97	10.16	5.84
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	79.47	9.28	4.95	4.95
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	216.41	8.06	5.53	4.14
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	99.01	7.50	5.33	1.94
carcinoid cell line:NCI-H1770	10703-109H1	228.50	11.28	14.11	3.29
carcinoid cell line:NCI-H727	10735-110B6	105.66	14.33	5.14	3.61
carcinoid cell line:SK-PN-DW	10719-109I8	82.71	3.17	1.58	4.75
carcinosarcoma cell line:JHUCS-1	10642-109A3	131.23	15.17	5.32	11.45
caudate nucleus - adult, donor10196	10177-103C6	82.90	5.76	1.15	2.30
caudate nucleus, adult, donor10252	10164-103B2	75.80	3.18	4.69	2.34
caudate nucleus, adult, donor10258	10379-105H1	91.70	1.53	3.06	1.53
caudate nucleus, newborn, donor10223	10354-105E3	151.99	1.46	2.56	1.83
cerebellum - adult, donor10196	10173-103C2	107.79	11.65	5.83	2.91
cerebellum, adult, donor10252	10166-103B4	72.59	5.55	1.28	1.28
cerebellum, adult, pool1	10083-102B2	53.12	2.41	1.72	1.72
cerebellum, newborn, donor10223	10357-105E6	174.36	2.49	1.66	4.15
cerebral meninges, adult	10188-103D8	95.31	4.29	3.28	2.77
cerebrospinal fluid, donor2	10294-104G6	41.66	3.65	2.92	3.65
cervical cancer cell line:D98-AH2	10552-107I3	272.76	11.65	4.89	13.95
cervical cancer cell line:ME-180	10553-107I4	135.22	10.44	4.14	0.83
cervix, adult, pool1	10013-101C4	60.89	4.72	1.36	1.68
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	120.25	13.52	5.57	1.67
chondrosarcoma cell line:SW 1353	10700-109G7	79.68	5.23	6.53	1.31
choriocarcinoma cell line:BeWo	10423-106C9	65.00	6.96	3.73	2.61
choriocarcinoma cell line:SCH	10785-110H2	120.38	6.28	4.19	1.97
choriocarcinoma cell line:T3M-3	10618-108G6	82.78	4.74	2.37	1.42
chorionic membrane cells, donor1	12238-129G6	57.55	4.84	1.14	1.42
chorionic membrane cells, donor2	12239-129G7	99.83	5.27	1.69	1.49
chorionic membrane cells, donor3	12240-129G8	68.14	5.49	2.20	1.10
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	88.86	5.05	23.23	2.02
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	69.16	3.65	4.80	2.69
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	64.83	4.43	5.70	3.38
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	151.26	7.19	10.02	3.08
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	144.89	8.47	7.74	4.84
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	161.67	9.37	4.07	3.87
chronic myelogenous leukemia cell line:K562	10454-106G4	154.59	12.96	12.66	1.77
chronic myelogenous leukemia cell line:KU812	10409-106B4	73.76	10.43	7.56	2.35
clear cell carcinoma cell line:JHOC-5	10638-108I8	130.52	4.80	2.51	4.57
clear cell carcinoma cell line:TEN	10636-108I6	151.82	12.49	5.21	6.07
colon carcinoma cell line:CACO-2	10513-107D9	160.53	10.62	3.84	5.13
colon carcinoma cell line:COLO-320	10420-106C6	107.18	9.88	4.94	3.80
colon, adult, donor1	10082-102B1	26.18	4.76	1.19	1.19
colon, adult, pool1	10014-101C5	70.74	4.70	3.64	0.47
colon, fetal, donor1	10070-101I7	64.89	5.56	1.85	2.47
common myeloid progenitor CMP, donor1	12130-128D6	50.42	9.17	27.50	13.75
common myeloid progenitor CMP, donor2	12134-128E1	50.07	0.00	25.04	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	254.53	17.00	8.50	27.62
cord blood derived cell line:COBL-a 24h infection	10453-106G3	169.65	7.70	5.74	25.36
cord blood derived cell line:COBL-a untreated	10449-106F8	174.43	7.61	6.63	28.48
corpus callosum, adult, pool1	10042-101F6	70.43	4.86	3.21	2.21
cruciate ligament, donor2	10295-104G7	59.97	9.73	1.62	1.62
diaphragm, fetal, donor1	10069-101I6	48.15	2.41	1.61	2.41
diencephalon, adult	10193-103E4	88.08	3.36	4.08	3.12
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	148.79	14.92	17.45	6.89
ductal cell carcinoma cell line:KLM-1	10438-106E6	210.02	9.23	5.13	6.67
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	230.37	5.30	3.13	5.54
ductus deferens, adult	10196-103E7	66.28	6.48	2.99	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	44.65	0.00	2.88	2.88
duodenum, fetal, donor1, tech_rep2	10071-101I8	78.71	3.68	2.21	1.47
dura mater, adult, donor1	10041-101F5	76.23	5.29	3.63	1.90
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	203.64	53.30	22.21	14.88
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	96.44	17.05	9.46	4.16
embryonic pancreas cell line:1B2C6	10604-108F1	78.93	6.17	2.47	3.70
embryonic pancreas cell line:1C3D3	10605-108F2	86.58	3.63	0.91	3.63
embryonic pancreas cell line:1C3IKEI	10606-108F3	90.77	7.10	2.78	4.01
embryonic pancreas cell line:2C6	10603-108E9	91.94	7.88	1.31	6.57
endometrial carcinoma cell line:OMC-2	10497-107C2	217.21	8.38	3.69	8.38
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	183.59	10.87	5.07	6.34
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	93.91	3.22	0.64	2.09
epidermoid carcinoma cell line:A431	10426-106D3	132.17	8.11	3.78	1.67
epidermoid carcinoma cell line:Ca Ski	10431-106D8	126.59	19.69	6.38	2.86
epididymis, adult	10197-103E8	57.98	3.56	2.93	1.26
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	111.59	12.24	6.56	3.02
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	81.01	7.47	5.11	6.29
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	92.13	16.77	7.47	3.80
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	97.53	16.93	8.56	4.43
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	89.74	16.24	8.74	2.80
esophagus, adult, pool1	10015-101C6	65.19	4.14	1.59	0.85
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	157.17	4.51	1.50	8.14
eye - muscle inferior rectus, donor1	10272-104E2	70.02	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	39.98	0.00	4.21	0.00
eye - muscle medial, donor2	10299-104H2	28.28	4.46	1.49	0.00
eye - muscle superior, donor2	10297-104G9	41.27	4.59	1.15	0.00
eye - vitreous humor, donor1	10268-104D7	26.23	14.57	2.91	1.46
eye, fetal, donor1	10054-101G9	54.41	4.83	3.31	1.78
fibrosarcoma cell line:HT-1080	10758-110E2	121.30	6.28	3.46	4.74
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	84.28	4.27	2.14	3.09
frontal lobe, adult, pool1	10040-101F4	71.96	3.94	3.00	1.97
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	116.80	6.61	4.20	4.20
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	226.31	9.69	6.03	2.65
gall bladder, adult	10198-103E9	43.94	4.35	1.93	0.97
gamma delta positive T cells, donor1	11937-126A2	94.49	5.91	9.13	0.54
gamma delta positive T cells, donor2	11938-126A3	115.41	9.71	13.45	0.75
gastric adenocarcinoma cell line:MKN1	10614-108G2	126.31	20.07	8.66	2.32
gastric adenocarcinoma cell line:MKN45	10612-108F9	146.42	9.09	4.26	0.39
gastric cancer cell line:AZ521	10549-107H9	243.47	13.28	7.38	14.10
gastric cancer cell line:GSS	10560-108A2	75.96	3.66	3.66	2.75
gastrointestinal carcinoma cell line:ECC12	10615-108G3	128.85	4.11	1.37	1.37
giant cell carcinoma cell line:LU65	10487-107B1	227.87	6.88	7.92	5.39
giant cell carcinoma cell line:Lu99B	10433-106E1	37.09	2.94	1.54	0.56
glassy cell carcinoma cell line:HOKUG	10688-109F4	116.73	6.24	4.49	3.24
glioblastoma cell line:A172, tech_rep1	10444-106F3	111.57	6.54	4.75	3.69
glioblastoma cell line:A172, tech_rep2	10444-106F3	119.23	7.58	4.21	4.35
glioblastoma cell line:T98G	10485-107A8	125.16	4.19	2.43	3.86
glioma cell line:GI-1	10413-106B8	134.43	6.74	3.81	5.86
globus pallidus - adult, donor10196	10175-103C4	72.89	2.92	0.73	2.92
globus pallidus, adult, donor10252	10161-103A8	77.62	5.61	2.69	1.71
globus pallidus, adult, donor10258	10367-105F7	101.32	4.11	2.74	1.37
globus pallidus, newborn, donor10223	10364-105F4	94.86	4.26	1.07	3.20
granulocyte macrophage progenitor, donor1	12131-128D7	24.47	9.79	17.13	4.89
granulocyte macrophage progenitor, donor2	12135-128E2	10.93	0.00	10.93	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	83.63	5.23	31.36	5.23
granulosa cell tumor cell line:KGN	10624-108H3	36.80	4.80	1.28	0.64
hIPS +CCl2, biol_rep1	14383-156B9	113.40	4.59	0.92	11.48
hIPS +CCl2, biol_rep2	14384-156C1	96.48	7.32	2.29	13.26
hIPS +CCl2, biol_rep3	14385-156C2	115.94	3.86	2.58	14.17
hIPS, biol_rep1	14380-156B6	143.73	7.19	1.44	11.50
hIPS, biol_rep2	14381-156B7	116.60	4.12	2.06	11.66
hIPS, biol_rep3	14382-156B8	92.69	5.52	4.41	2.21
hairy cell leukemia cell line:Mo	10712-109I1	79.31	8.33	5.75	3.16
heart - mitral valve, adult	10205-103F7	53.22	3.89	0.90	1.20
heart - pulmonic valve, adult	10206-103F8	40.01	2.35	1.57	1.05
heart - tricuspid valve, adult	10207-103F9	61.62	2.50	3.33	2.50
heart, adult, diseased post-infarction, donor1	10050-101G5	75.30	3.26	1.63	1.02
heart, adult, diseased, donor1	10051-101G6	31.51	2.55	0.85	0.00
heart, adult, pool1	10016-101C7	54.27	2.76	1.15	0.00
heart, fetal, pool1	10046-101G1	61.71	4.52	1.85	0.92
hepatic mesenchymal tumor cell line:LI90	10778-110G4	84.84	0.62	0.93	2.47
hepatoblastoma cell line:HuH-6	10633-108I3	110.59	20.22	5.95	14.27
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	49.28	9.83	2.87	3.43
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	58.38	10.32	4.13	2.06
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	52.24	7.28	3.74	3.23
hepatoma cell line:Li-7	10484-107A7	228.21	14.57	6.56	6.23
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	133.26	4.32	4.22	4.92
hippocampus - adult, donor10196	10169-103B7	108.83	4.73	0.95	2.84
hippocampus, adult, donor10252	10153-102I9	69.60	4.49	1.84	1.84
hippocampus, adult, donor10258	10374-105G5	82.16	8.96	1.99	1.49
hippocampus, newborn, donor10223	10363-105F3	87.77	4.23	2.11	2.11
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	204.47	13.43	7.32	25.02
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	76.38	9.43	4.52	11.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	100.54	7.11	3.81	14.73
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	50.75	10.15	1.13	10.15
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	48.80	5.16	3.36	11.62
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	57.70	7.97	6.83	20.50
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	92.55	7.88	1.75	15.18
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	65.92	5.60	2.80	11.42
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	85.50	6.67	0.83	18.77
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	102.77	7.10	3.32	14.68
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	69.43	6.27	3.38	11.57
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	101.00	11.45	2.69	15.49
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	69.64	6.73	2.97	10.80
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	76.64	7.37	5.90	15.72
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	208.59	6.98	3.49	21.82
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	41.81	7.45	4.01	12.03
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	44.48	4.80	3.05	11.34
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	88.46	7.50	1.00	20.49
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	60.10	1.88	1.51	8.29
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	72.75	3.64	2.27	7.73
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	86.77	4.07	1.25	13.47
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	68.75	5.23	1.47	8.49
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	66.77	3.77	1.45	8.13
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	88.78	3.59	0.90	12.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	84.80	7.39	3.14	9.24
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	75.60	7.42	4.85	8.84
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	171.08	11.43	3.67	25.32
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	70.06	2.82	2.11	8.10
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	44.98	6.02	2.53	9.19
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	63.55	5.14	2.72	14.22
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	76.53	5.69	1.55	6.21
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	66.42	5.31	1.33	8.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	74.65	6.16	0.77	6.93
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	73.12	4.35	2.05	9.71
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	90.87	8.33	0.76	9.84
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	91.74	3.36	2.02	12.77
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	70.52	7.25	2.90	9.66
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	111.41	12.03	5.35	13.82
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	89.76	8.78	3.90	25.85
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	45.84	6.11	1.83	13.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	429.43	45.55	3.25	74.82
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	92.00	7.94	2.32	25.48
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	77.17	8.21	1.09	12.59
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	75.27	6.15	2.17	11.94
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	72.95	4.63	0.71	15.66
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	56.09	3.58	2.39	11.93
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	91.95	5.69	1.49	12.05
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	78.39	4.31	2.69	10.78
immature langerhans cells, donor1	11904-125F5	112.36	1.70	5.33	2.18
immature langerhans cells, donor2	11905-125F6	85.55	2.38	3.96	0.79
insula, adult, pool1	10039-101F3	79.02	4.16	2.84	2.37
keratoacanthoma cell line:HKA-1	10791-110H8	96.24	7.48	4.23	2.28
kidney, adult, pool1	10017-101C8	74.49	6.61	3.60	1.70
kidney, fetal, pool1	10045-101F9	53.05	4.95	2.90	2.26
large cell lung carcinoma cell line:IA-LM	10509-107D5	124.98	11.79	7.10	6.96
large cell lung carcinoma cell line:NCI-H460	10839-111E2	87.51	7.74	5.53	1.80
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	71.75	7.71	3.12	1.47
left atrium, adult, donor1	10079-102A7	27.24	1.09	1.09	0.54
left ventricle, adult, donor1	10078-102A6	30.84	1.01	0.00	1.01
leiomyoblastoma cell line:G-402	10721-110A1	63.75	3.28	1.92	1.92
leiomyoma cell line:10964C	10569-108B2	74.36	5.03	5.03	1.80
leiomyoma cell line:15242A	10570-108B3	72.28	2.72	2.17	0.54
leiomyoma cell line:15425	10571-108B4	89.84	2.91	3.16	0.49
leiomyosarcoma cell line:Hs 5.T	10722-110A2	146.04	19.05	6.35	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	67.96	23.00	5.23	5.23
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	133.05	8.26	2.83	5.31
liposarcoma cell line:KMLS-1	10782-110G8	64.05	2.19	1.72	1.25
liposarcoma cell line:SW 872	10726-110A6	95.64	10.48	5.48	3.66
liver, adult, pool1	10018-101C9	48.62	4.86	3.40	0.81
liver, fetal, pool1	10086-102B5	32.92	4.70	0.94	0.94
locus coeruleus - adult, donor10196	10182-103D2	72.47	5.98	3.06	2.04
locus coeruleus, adult, donor10252	10165-103B3	69.39	6.83	2.40	1.29
locus coeruleus, adult, donor10258	10375-105G6	40.06	2.26	1.41	1.13
locus coeruleus, newborn, donor10223	10362-105F2	129.97	3.79	0.84	4.21
lung adenocarcinoma cell line:A549	10499-107C4	119.99	6.37	3.88	2.63
lung adenocarcinoma cell line:PC-14	10408-106B3	55.84	7.58	4.83	4.14
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	111.91	12.65	5.14	8.96
lung, adult, pool1	10019-101D1	54.93	4.25	2.72	1.42
lung, fetal, donor1	10068-101I5	109.31	6.85	4.28	5.42
lung, right lower lobe, adult, donor1	10075-102A3	43.53	4.12	2.75	0.46
lymph node, adult, donor1	10077-102A5	41.66	1.89	3.79	0.95
lymphangiectasia cell line:DS-1	10727-110A7	85.48	12.27	10.74	4.60
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	456.85	32.90	36.07	7.24
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	169.90	11.04	0.85	0.00
mature adipocyte, donor1	12231-129F8	74.15	6.66	3.55	1.78
mature adipocyte, donor2	12232-129F9	81.56	6.43	3.11	1.66
mature adipocyte, donor3	12233-129G1	68.99	5.93	1.42	1.42
mature adipocyte, donor4	12234-129G2	78.97	6.32	3.69	2.11
maxillary sinus tumor cell line:HSQ-89	10414-106B9	319.74	16.20	4.53	3.34
medial frontal gyrus - adult, donor10196	10170-103B8	91.37	4.51	2.26	1.13
medial frontal gyrus, adult, donor10252	10150-102I6	69.15	8.09	3.31	1.84
medial frontal gyrus, adult, donor10258	10368-105F8	80.37	5.40	1.59	3.49
medial frontal gyrus, newborn, donor10223	10352-105E1	251.63	5.12	1.28	8.53
medial temporal gyrus - adult, donor10196	10183-103D3	89.94	5.57	2.70	2.53
medial temporal gyrus, adult, donor10252	10156-103A3	78.52	7.85	2.97	1.27
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	109.80	5.78	1.93	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	229.66	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	112.35	2.15	1.44	3.59
medulla oblongata - adult, donor10196	10174-103C3	85.02	1.30	1.95	7.14
medulla oblongata, adult, donor10252	10155-103A2	57.90	5.26	2.01	1.70
medulla oblongata, adult, pool1	10038-101F2	73.79	6.37	3.51	2.12
medulla oblongata, newborn, donor10223	10361-105F1	91.31	3.82	3.12	2.08
medulloblastoma cell line:D283 Med	10838-111E1	54.02	3.10	3.76	3.76
medulloblastoma cell line:ONS-76	10759-110E3	119.22	6.73	2.93	3.67
melanoma cell line:COLO 679	10514-107E1	161.43	6.47	2.44	4.74
melanoma cell line:G-361	10465-106H6	136.55	5.43	2.99	6.52
meningioma cell line:HKBMM	10691-109F7	64.40	3.08	2.53	0.54
merkel cell carcinoma cell line:MKL-1	10843-111E6	96.05	11.46	5.29	9.69
merkel cell carcinoma cell line:MS-1	10844-111E7	148.79	9.07	8.30	4.93
mesenchymal precursor cell - adipose, donor1	11747-123G1	109.71	5.22	2.76	2.45
mesenchymal precursor cell - adipose, donor2	11748-123G2	108.34	3.64	2.36	2.54
mesenchymal precursor cell - adipose, donor3	11749-123G3	81.99	4.56	1.66	0.83
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	84.14	3.79	2.25	2.25
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	66.63	4.04	1.93	1.35
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	71.49	3.47	0.69	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	85.82	4.29	2.23	2.40
mesenchymal precursor cell - cardiac, donor2	11753-123G7	70.16	3.34	2.53	2.19
mesenchymal precursor cell - cardiac, donor3	11754-123G8	84.22	6.10	3.98	2.92
mesenchymal precursor cell - cardiac, donor4	11755-123G9	87.51	5.54	2.57	1.76
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	75.11	3.70	2.56	0.85
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	58.95	6.26	2.63	2.31
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	76.38	5.67	3.04	1.80
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	75.75	5.93	2.09	0.70
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	82.69	4.29	3.27	2.65
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	51.40	3.95	1.44	1.44
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	52.55	3.41	2.28	1.45
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	40.13	2.28	1.14	0.91
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	112.02	2.52	0.84	3.78
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	64.41	5.68	3.74	2.09
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	65.91	6.83	2.45	2.54
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	58.17	7.00	2.58	1.10
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	50.94	5.15	1.72	1.72
mesenchymal stem cell line:Hu5/E18	10568-108B1	101.46	5.89	2.95	2.11
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	99.10	1.37	3.65	2.74
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	121.50	2.81	2.05	3.58
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	110.98	2.88	1.31	2.62
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	96.12	3.39	2.16	4.01
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	106.38	2.35	1.41	2.12
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	99.51	2.71	2.37	3.72
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	107.67	2.75	2.36	2.36
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	92.21	5.10	2.32	2.32
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	241.52	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	129.50	2.31	1.44	2.88
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	105.30	2.90	1.34	2.23
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	111.52	3.36	3.61	4.33
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	85.80	2.20	1.47	4.40
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	93.98	1.01	1.34	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	113.40	2.46	2.05	4.50
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	106.53	2.15	2.15	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	87.50	16.41	2.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	77.47	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	112.70	4.55	1.95	3.25
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	103.30	0.00	5.82	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	109.81	3.73	5.33	7.46
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	83.41	4.09	1.64	1.64
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	92.52	4.28	3.50	3.11
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	73.46	6.30	0.00	2.10
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	83.45	5.96	1.99	4.97
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	81.04	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	106.73	3.56	2.96	4.15
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	88.95	1.22	1.22	4.87
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	81.16	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	98.81	4.43	0.63	2.53
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	85.19	2.76	1.03	3.10
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	98.86	4.30	4.30	6.45
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	67.86	3.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	86.10	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	75.79	2.85	1.22	4.07
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	54.02	4.77	4.77	2.38
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	57.77	4.13	0.59	1.77
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	59.22	3.43	1.56	0.94
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	54.80	1.34	2.67	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	41.39	3.55	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	59.06	2.57	0.00	2.57
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	51.63	3.44	0.00	2.07
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	53.93	5.44	1.98	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	41.50	6.73	2.24	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	55.97	3.82	5.72	1.91
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	68.10	6.45	3.63	1.61
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	58.88	13.08	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	63.35	1.27	6.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	77.07	8.50	4.25	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	81.34	9.04	4.52	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	58.48	8.24	2.47	1.65
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	66.27	3.97	2.38	0.40
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	52.89	3.24	3.57	0.97
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	39.73	2.04	1.02	2.04
mesodermal tumor cell line:HIRS-BM	10696-109G3	60.35	6.19	3.09	4.64
mesothelioma cell line:ACC-MESO-1	10493-107B7	285.85	8.27	6.85	3.31
mesothelioma cell line:ACC-MESO-4	10494-107B8	134.60	7.41	2.32	6.49
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	59.83	4.27	4.27	4.27
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	113.44	10.17	1.75	1.75
mesothelioma cell line:Mero-25	10850-111F4	111.21	2.50	0.91	6.35
mesothelioma cell line:Mero-41	10851-111F5	135.93	3.91	4.40	4.16
mesothelioma cell line:Mero-48a	10852-111F6	112.93	8.19	2.66	1.77
mesothelioma cell line:Mero-82	10853-111F7	140.60	8.15	2.63	7.88
mesothelioma cell line:Mero-83	10854-111F8	58.90	11.58	2.21	1.19
mesothelioma cell line:Mero-84	10855-111F9	87.97	10.87	8.34	2.02
mesothelioma cell line:Mero-95	10856-111G1	86.13	9.11	4.35	3.11
mesothelioma cell line:NCI-H2052	10847-111F1	60.13	3.98	0.83	0.50
mesothelioma cell line:NCI-H226	10846-111E9	114.21	10.68	5.79	3.08
mesothelioma cell line:NCI-H2452	10848-111F2	138.20	9.91	3.76	4.44
mesothelioma cell line:NCI-H28	10845-111E8	88.55	3.31	2.80	2.04
mesothelioma cell line:No36	10857-111G2	75.35	9.79	6.52	1.63
mesothelioma cell line:ONE58	10858-111G3	100.25	8.13	3.52	2.98
migratory langerhans cells, donor1	11901-125F2	111.70	0.58	1.15	2.88
migratory langerhans cells, donor2	11902-125F3	74.73	0.37	0.85	1.22
migratory langerhans cells, donor3	11903-125F4	70.36	0.72	0.54	2.51
mixed mullerian tumor cell line:HTMMT	10689-109F5	194.91	8.49	4.57	2.94
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	64.43	1.91	0.42	1.06
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	226.90	16.82	11.06	4.84
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	65.08	4.76	6.09	3.43
myelodysplastic syndrome cell line:SKM-1	10772-110F7	141.92	8.13	6.84	3.33
myeloma cell line:PCM6	10474-106I6	265.27	4.74	4.94	5.34
myxofibrosarcoma cell line:MFH-ino	10600-108E6	90.80	5.58	4.57	2.03
myxofibrosarcoma cell line:NMFH-1	10684-109E9	158.87	19.81	6.86	8.04
nasal epithelial cells, donor1, tech_rep1	12226-129F3	112.32	5.01	3.57	0.78
nasal epithelial cells, donor1, tech_rep2	12226-129F3	132.45	4.78	4.04	0.96
nasal epithelial cells, donor2	12227-129F4	80.59	4.97	2.76	0.55
neuroblastoma cell line:CHP-134	10508-107D4	116.41	8.51	10.12	27.61
neuroblastoma cell line:NB-1	10539-107G8	106.26	10.66	5.05	4.30
neuroblastoma cell line:NBsusSR	10607-108F4	141.72	5.27	2.53	11.39
neuroblastoma cell line:NH-12	10555-107I6	107.15	11.93	5.78	13.23
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	92.28	3.32	4.03	9.73
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	116.09	5.07	4.43	4.43
neuroectodermal tumor cell line:TASK1	10774-110F9	101.23	11.47	12.48	5.23
neuroepithelioma cell line:SK-N-MC	10728-110A8	79.47	6.99	8.90	12.72
neurofibroma cell line:Hs 53.T	10729-110A9	83.31	5.59	1.60	2.93
neutrophil PMN, donor1	12133-128D9	29.75	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	66.40	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	75.77	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	151.02	4.90	5.41	3.21
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	204.13	5.60	3.20	4.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	113.82	5.45	2.24	3.53
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	105.63	2.89	2.36	2.10
nucleus accumbens, adult, pool1	10037-101F1	71.99	2.62	4.31	1.87
occipital cortex - adult, donor10196	10172-103C1	72.11	6.18	0.00	2.06
occipital cortex, adult, donor10252	10163-103B1	86.41	6.98	2.42	1.07
occipital cortex, newborn, donor10223	10355-105E4	105.18	4.37	3.28	3.28
occipital lobe, adult, donor1	10076-102A4	71.11	4.46	2.36	2.10
occipital lobe, fetal, donor1	10073-102A1	85.82	3.43	3.86	12.87
occipital pole, adult, pool1	10036-101E9	63.31	3.15	2.76	1.89
olfactory region, adult	10195-103E6	57.32	2.48	1.91	1.91
optic nerve, donor1	10277-104E7	90.05	6.00	0.00	4.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	77.23	4.10	1.03	2.05
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	236.99	8.11	5.08	4.26
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	57.40	6.77	2.71	1.69
oral squamous cell carcinoma cell line:SAS	10544-107H4	181.93	7.97	5.08	6.12
osteoclastoma cell line:Hs 706.T	10704-109H2	92.31	3.23	2.35	2.65
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	122.40	21.49	11.21	3.74
osteosarcoma cell line:HS-Os-1	10558-107I9	121.72	7.42	4.88	2.97
ovary, adult, pool1	10020-101D2	53.55	4.11	1.83	2.88
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	112.01	4.58	2.57	3.85
pancreas, adult, donor1	10049-101G4	56.44	1.88	2.82	2.82
pancreatic carcinoma cell line:NOR-P1	10698-109G5	60.94	7.27	4.19	3.35
papillary adenocarcinoma cell line:8505C	10437-106E5	69.50	13.12	4.94	5.79
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	630.37	45.37	23.02	11.43
paracentral gyrus, adult, pool1	10035-101E8	68.18	5.03	3.11	2.01
parietal cortex, adult, donor10258	10373-105G4	73.40	4.40	0.73	2.94
parietal lobe - adult, donor10196	10171-103B9	65.83	5.64	1.88	0.00
parietal lobe, adult, donor10252	10157-103A4	70.97	5.70	2.85	2.85
parietal lobe, adult, pool1	10034-101E7	68.65	4.93	2.64	1.67
parietal lobe, fetal, donor1	10072-101I9	122.20	6.79	2.91	11.64
parietal lobe, newborn, donor10223	10356-105E5	122.63	7.10	2.99	2.62
parotid gland, adult	10199-103F1	54.88	15.42	4.93	1.23
penis, adult	10200-103F2	44.04	2.15	1.61	1.61
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	303.45	14.32	14.32	5.95
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	148.61	11.36	6.26	3.21
pineal gland - adult, donor10196	10179-103C8	78.05	5.81	1.29	2.58
pineal gland, adult, donor10252	10160-103A7	91.20	5.33	3.55	2.96
pineal gland, adult, donor10258	10377-105G8	67.72	4.39	1.88	0.63
pituitary gland - adult, donor10196	10180-103C9	104.22	7.08	1.01	5.06
pituitary gland, adult, donor10252	10162-103A9	123.00	16.16	3.65	7.30
pituitary gland, adult, donor10258	10378-105G9	77.46	10.21	2.55	3.40
placenta, adult, pool1	10021-101D3	64.50	2.80	1.83	0.75
plasma cell leukemia cell line:ARH-77	10840-111E3	141.70	13.11	9.14	2.12
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	96.34	2.80	1.71	2.02
pons, adult, pool1	10033-101E6	70.49	4.91	2.58	1.46
postcentral gyrus, adult, pool1	10032-101E5	74.10	4.88	4.45	2.88
promyelocytes/myelocytes PMC, donor1	12132-128D8	23.01	10.46	2.09	2.09
promyelocytes/myelocytes PMC, donor2	12136-128E3	71.60	11.02	5.51	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	82.15	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	128.04	13.55	7.57	5.68
prostate cancer cell line:PC-3	10439-106E7	153.19	18.33	7.26	4.90
prostate, adult, pool1	10022-101D4	50.42	2.72	2.09	1.00
putamen, adult, donor10196	10176-103C5	71.53	2.60	5.43	1.42
putamen, adult, donor10252	10152-102I8	115.68	1.96	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	76.50	5.46	2.19	6.56
putamen, adult, donor10258, tech_rep2	10372-105G3	71.28	2.42	4.35	0.97
putamen, newborn, donor10223	10365-105F5	255.63	2.25	3.00	2.25
rectal cancer cell line:TT1TKB	10469-106I1	203.07	9.31	3.49	2.62
rectum, fetal, donor1	10067-101I4	48.68	4.17	5.56	2.78
renal cell carcinoma cell line:OS-RC-2	10411-106B6	140.77	3.39	3.18	1.27
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	224.50	4.56	5.38	3.31
retina, adult, pool1	10030-101E3	54.77	4.77	2.68	1.39
retinoblastoma cell line:Y79	10475-106I7	115.09	5.98	5.98	8.83
rhabdomyosarcoma cell line:KYM-1	10787-110H4	97.74	4.18	0.74	5.66
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	421.52	19.12	11.25	37.96
sacrococcigeal teratoma cell line:HTST	10695-109G2	75.79	0.76	4.55	2.27
salivary acinar cells, donor1	11771-123I7	56.81	3.40	3.40	0.97
salivary acinar cells, donor2	11772-123I8	48.47	2.48	3.03	2.89
salivary acinar cells, donor3	11773-123I9	42.37	3.97	0.66	3.31
salivary gland, adult, pool1	10093-102C3	58.34	8.01	5.72	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	95.78	5.73	6.49	5.31
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	115.55	5.88	4.82	5.88
seminal vesicle, adult	10201-103F3	51.85	2.65	1.06	2.12
serous adenocarcinoma cell line:JHOS-2	10639-108I9	67.53	5.34	0.97	1.46
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	54.35	8.81	2.77	1.26
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	61.22	5.02	3.01	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	129.35	5.51	1.75	1.88
signet ring carcinoma cell line:Kato III	10436-106E4	199.94	5.75	3.76	4.31
signet ring carcinoma cell line:NUGC-4	10483-107A6	95.87	10.97	6.71	1.42
skeletal muscle - soleus muscle, donor1	10282-104F3	39.01	0.71	0.71	1.42
skeletal muscle, adult, pool1	10023-101D5	42.70	1.44	0.60	0.96
skeletal muscle, fetal, donor1	10066-101I3	33.17	3.02	5.03	1.01
skin, adult, donor1	10074-102A2	40.71	6.79	13.57	0.00
skin, fetal, donor1	10065-101I2	75.75	3.79	1.89	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	95.05	6.34	5.00	6.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	104.65	21.12	6.93	3.47
small cell lung carcinoma cell line:DMS 144	10841-111E4	177.71	6.75	4.63	3.47
small cell lung carcinoma cell line:LK-2	10541-107H1	253.83	15.33	9.56	18.63
small cell lung carcinoma cell line:NCI-H82	10842-111E5	150.72	9.97	9.01	1.93
small cell lung carcinoma cell line:WA-hT	10562-108A4	193.95	25.28	5.67	18.31
small intestine, adult, pool1	10024-101D6	75.97	7.64	2.87	1.07
small intestine, fetal, donor1	10064-101I1	69.04	4.67	2.95	1.23
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	307.23	14.36	5.64	3.08
smooth muscle, adult, pool1	10048-101G3	41.09	1.81	2.33	0.78
somatostatinoma cell line:QGP-1	10781-110G7	149.02	6.70	3.22	4.56
spinal cord - adult, donor10196	10181-103D1	76.39	2.98	2.75	1.38
spinal cord, adult, donor10252	10159-103A6	80.83	5.52	2.76	0.79
spinal cord, adult, donor10258	10369-105F9	113.45	2.77	1.38	2.77
spinal cord, fetal, donor1	10056-101H2	68.30	4.88	1.83	5.49
spinal cord, newborn, donor10223	10359-105E8	172.66	7.81	1.84	4.13
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	105.00	2.99	2.24	1.79
spleen, adult, pool1	10025-101D7	50.22	7.16	3.85	1.54
spleen, fetal, pool1	10044-101F8	51.41	6.59	4.69	1.03
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	126.28	3.83	4.14	3.62
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	180.00	11.96	5.32	2.85
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	140.83	9.44	3.49	3.84
squamous cell carcinoma cell line:T3M-5	10616-108G4	501.56	28.93	10.56	4.30
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	746.83	29.83	22.85	8.67
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	91.07	7.20	0.85	2.12
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	79.11	16.92	6.35	11.00
stomach, fetal, donor1	10062-101H8	76.89	8.54	3.20	0.00
submaxillary gland, adult	10202-103F4	49.56	6.27	4.56	1.14
substantia nigra - adult, donor10196	10178-103C7	54.27	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	64.18	4.36	1.87	1.87
substantia nigra, adult, donor10258	10371-105G2	89.48	4.66	3.62	4.14
substantia nigra, newborn, donor10223	10358-105E7	91.15	3.53	0.71	4.24
synovial sarcoma cell line:HS-SY-II	10441-106E9	165.76	7.80	2.98	10.09
temporal lobe, adult, pool1	10031-101E4	59.25	4.49	3.65	2.20
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	76.21	2.14	4.27	12.11
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	72.96	5.71	2.64	14.50
tenocyte, donor1	11763-123H8	76.10	2.44	3.14	2.09
tenocyte, donor2	11765-123I1	59.13	5.72	1.53	1.14
tenocyte, donor3	11768-123I4	75.62	4.45	3.34	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	97.73	5.10	5.10	11.56
teratocarcinoma cell line:NCR-G1	10798-110I6	102.97	5.24	4.62	6.17
teratocarcinoma cell line:PA-1	10807-111A6	61.99	9.30	3.87	6.66
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	71.85	4.32	2.41	4.95
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	155.43	1.89	1.89	22.31
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	105.03	5.02	2.07	8.18
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	80.77	2.61	1.95	20.84
testis, adult, pool1	10026-101D8	97.71	5.91	12.24	13.10
testis, adult, pool2	10096-102C6	112.77	13.53	24.81	35.64
thalamus - adult, donor10196	10168-103B6	125.85	4.42	2.21	4.42
thalamus, adult, donor10252	10154-103A1	72.20	4.69	3.13	0.78
thalamus, adult, donor10258, tech_rep1	10370-105G1	167.82	21.55	0.00	1.54
thalamus, adult, donor10258, tech_rep2	10370-105G1	56.49	3.62	1.15	1.48
thalamus, newborn, donor10223	10366-105F6	162.82	2.30	0.58	1.73
throat, adult	10209-103G2	55.18	3.00	1.75	2.00
throat, fetal, donor1	10061-101H7	69.78	4.27	3.05	1.22
thymic carcinoma cell line:Ty-82	10803-111A2	100.36	7.15	2.58	6.76
thymus, adult, pool1	10027-101D9	43.15	3.38	8.85	2.88
thymus, fetal, pool1	10043-101F7	60.06	3.32	7.59	2.08
thyroid carcinoma cell line:KHM-5M	10776-110G2	149.85	10.11	3.99	5.72
thyroid carcinoma cell line:TCO-1	10783-110G9	91.64	9.92	4.89	5.59
thyroid, adult, pool1	10028-101E1	86.78	8.12	3.08	3.45
thyroid, fetal, donor1	10060-101H6	58.27	5.27	1.85	1.58
tongue epidermis (fungiform papillae), donor1	10288-104F9	46.19	6.16	0.00	0.00
tongue, adult	10203-103F5	48.14	5.58	2.09	1.40
tongue, fetal, donor1	10059-101H5	65.81	2.76	3.15	0.39
tonsil, adult, pool1	10047-101G2	73.63	5.11	7.01	0.60
trachea, adult, pool1	10029-101E2	63.15	5.24	3.44	0.90
trachea, fetal, donor1	10058-101H4	57.70	4.62	1.92	1.54
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	90.34	4.25	1.77	2.83
transitional-cell carcinoma cell line:5637	10418-106C4	151.97	10.44	4.36	8.51
transitional-cell carcinoma cell line:JMSU1	10492-107B6	123.00	6.58	1.88	4.23
tridermal teratoma cell line:HGRT	10694-109G1	112.25	7.61	0.00	7.61
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	99.72	7.70	4.57	5.08
umbilical cord, fetal, donor1	10057-101H3	77.20	6.26	0.00	0.00
uterus, adult, pool1	10100-102D1	56.82	4.78	1.54	2.22
uterus, fetal, donor1	10055-101H1	62.97	5.12	2.56	2.05
vagina, adult	10204-103F6	43.30	7.11	1.94	0.00
vein, adult	10191-103E2	35.07	5.70	2.85	0.88
xeroderma pigentosum b cell line:XPL 17	10563-108A5	63.02	2.67	3.74	1.87